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Abstract 
Patients in critical care with lung injuries need to be assisted with regards to 
breathing function, but current methods are not applicable for all situations. The 
most common method, Extracorporeal Membrane Oxygenation (ECMO) is an 
expensive procedure and requires trained staff to operate the equipment at all 
times. Lung injury may lead to the inability of the lungs to be perfused and the 
blood oxygenated by tracheal intubation, whereas mechanical ventilators can 
injure the lungs further. Especially at risk are preterm neonates, where congenital 
disorders or complications during birth render ECMO the only viable option. 
Respiratory Assist Catheters (RACs) could be used as an alternative because they 
do not place extra stress on the lungs, are easy to implement, cost-effective and 
are available for immediate use in clinical settings or in first aid situations. The 
development of such a device requires knowledge of possible oxygenation 
methods as well as the risks involved in implementing such a device. The 
possibility of oxygenating the blood via microbubbles by means of a RAC is 
promising due to the high gas transfer rates common in bubble oxygenators. It is 
the aim of this study to develop a prototype that could function as a RAC and to 
evaluate the feasibility of oxygenation by using microbubbles.   
 
The method used to design a prototype included selection of various materials and 
finalization of a design to be tested. The tests selected were in vivo tests and ex 
vivo tests using animal models to investigate the dissolution times of the 
microbubbles, as well as the physiological effects of an intravenously placed 
device. Measurements of oxygen saturation of the blood in arterial blood (SaO2), 
venous blood (SvO2) and pulmonary pressure allowed the oxygen transfer rates 
and risks involved to be evaluated, and also gave an indication regarding the 
formation dynamics of microbubbles in the blood. An in vitro test was also 
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performed with the aim of determining the rate of dissolving of oxygen, and hence 
to give an indication regarding microbubble dissolution times. Mathematical 
simulations based on the dissolution rate of oxygen in venous blood confirmed the 
abovementioned results.  
 
The tests and simulations were analysed in order to evaluate the feasibility of 
intravenously oxygenating the blood using microbubbles. Approximate bubble 
dissolution times were an indicator of the feasibility of the concept and showed 
that very large bubble dissolution times renders intravenous bubble oxygenation 
unfeasible. These large dissolution times also lessen the possibility of 
implementing bubble oxygenation in an intravenous device.  
 
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
iv 
 
 
 
Uittreksel 
Pasiënte wat a.g.v. longbeserings in hoë-sorg behandel word het hulp nodig om 
asem te haal, maar bestaande metodes werk nie in alle omstandighede nie. Die 
mees algemene metode is ekstrakorporeale membraan suurstofverbinding 
(Extracorporeal Membrane Oxygenation (ECMO)), maar hierdie metode is duur 
en het voltyds opgeleide personeel nodig om dit te beheer. Longbeserings kan lei 
tot die onvermoë van die longe om bloed te ontvang en ook dat die bloed suurstof 
kry d.m.v. trageale intubasie. Meganiese ventilators kan die longe verder 
beskadig. Vroeggebore babas word blootgestel aan risiko’s veral waar oorerflike 
afwykings/steurnisse aanwesig is of komplikasies tydens geboorte en dus die 
EMCO die enigste lewensvatbare opsie maak. Kateters wat asemhaling aanhelp 
(Respiratory Assist Catheters (RACs)) kan as alternatief gebruik word aangesien 
dit nie ekstra spanning op die longe plaas nie, maklik is om te implementeer, 
koste-effektief is en beskikbaar is vir onmiddellike gebruik in kliniese 
omstandighede of in noodhulpsituasies. Die ontwikkeling van hierdie tipe toestel 
vereis kennis van moontlike suurstofverbindingsmetodes en ook die risiko’s 
verbonde aan die implementering van die toestel. Die moontlikheid om die bloed 
van suurstof te voorsien d.m.v. mikroborrels deur die RAC lyk belowend a.g.v. 
die hoë gasoordrag-koers wat algemeen is by borrel suurstofverbinders. Hierdie 
studie het ten doel om ŉ prototipe te ontwikkel wat kan dien as ŉ RAC en ook om 
die lewensvatbaarheid van suurstofverbinding met mikroborrels te bepaal. 
 
Die metode wat gebruik is om die prototipe te ontwerp sluit in die kies van 
verskeie materiale en die finalisering van die ontwerp wat getoets moet word. Die 
geselekteerde in vivo en ex vivo toetse is afgeneem deur gebruik te maak van 
dier-modelle om sodoende ondersoek in te stel na die oplossing van die 
mikroborrels en ook die fisiologiese gevolge van die toestel wat binne die aar 
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geplaas is. Metings van die suurstofversadiging van bloed in slagaarbloed (SaO2), 
aarbloed (SvO2) en pulmonêre druk het toegelaat dat die koers en risiko’s 
verbonde aan suurstofoordrag geëvalueer word. Hierdie metings gee ook ’n 
aanduiding van die vormingsdinamika van die mikroborrels in die bloed. ’n In 
vitro toets is gedoen met die doel om die koers te bepaal van die oplossing van 
suurstof, en dus ’n aanduiding te gee van die tyd verbonde aan die oplossing van 
die mikroborrels. Wiskundige simulasies gebaseer op die oplossingskoers van 
suurstof in are het die bogenoemde toetse bevestig. 
 
Die toetse en simulasies is geanaliseer om die lewensvatbaarheid te bepaal om 
suurstof binne-aars te verskaf deur mikroborrels. Geskatte tye waarteen die 
borrels oplos is as aanduiding gebruik vir die lewensvatbaarheid van die konsep 
en ook die moontlike inwerkingstelling van die binne-aarse toestel. 
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A-aDO2 Alveolar-arterial oxygenation gradient 
CaCO2 Arterial carbon dioxide content 
c Haemoglobin binding capacity 
Cd Mass fraction of dissolved oxygen in the blood 
CO Cardiac Output 
CvO2 Venous oxygen content 
D Diffusion constant 
Hb Haemoglobin 
HbO2 Haemoglobin-bound oxygen 
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Definitions 
Acidosis Increased acidity of the blood 
Blood/Device interaction The interaction between a device and the whole 
blood or part of the blood which results in an effect 
on the blood, downstream organs or on the device 
itself (ISO 2002) 
Bubble point pressure 
The pressure required to form a gas bubble through 
a small orifice for a specific fluid, gas and pore size 
Embolectomy catheter A catheter used to surgically remove emboli in the 
blood circulation system. 
Embolism The act of clogging of an arterial capillary due to an 
embolus 
Embolus Any object that can obstruct an arterial capillary 
Erythrocyte Red blood cell 
Extracorporeal A process or machine which is placed or occurs 
outside of the body 
Ex vivo Describes the test setup that allows blood to be 
shunted from a human subject or test animal outside 
the body (ISO 2002) 
Haemolysis The release of haemoglobin from ruptured red blood 
cells 
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Heparin A widely used injectable anticoagulant 
Hydrophilic Surfaces that have a strong affinity for water 
Hydrophobic Surfaces that lack an affinity for water 
Hypoxemia Decreased partial pressure of oxygen in arterial 
blood, could lead to hypoxia 
Hypoxia When the body or tissue does not receive an 
adequate oxygen supply 
Intravenous Within the veins 
In vitro Outside of a living system, usually within a test tube 
or petri dish 
In vivo Within a living organism 
MAS Meconium Aspiration Syndrome is a condition 
where the new-born breathes in a mixture of 
meconium and amniotic fluid into the lungs during 
birth 
Myopia A refractive defect of the eye (near-sightedness) 
Necrosis Cell death, death of body tissue 
Oxygenation Index The ration of oxygen being delivered to the lungs to 
the amount diffusing into the blood 
Perfusion The act of injecting a fluid into a blood vessel in 
order to reach the organs or tissue. 
PPHN Persistent Pulmonary Hypertension of the New-born 
is characterised by high pressure in the lung 
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capillaries, allowing blood to be directed away from 
the lungs 
Preterm neonate A child born before full term, and younger than 28 
days 
Pulmonary Pertaining to or affecting the lungs 
RAC A Respiratory Assist Catheter is an intravenous 
device that assist with oxygenation of the blood  
RDS Respiratory Distress Syndrome is characterised by 
the underdevelopment of the lungs, mostly seen by 
the collapse of alveoli due to insufficient surfactant 
production 
ROP 
 
In extreme cases Retinopathy of Prematurity can 
lead to blindness due to oxygen toxicity or hypoxia, 
of which preterm neonates are especially at risk. 
Shunt May be an anatomical or physiological occurrence 
where fluid is moved through the lungs to the other 
without being oxygenated 
Thrombosis A mixture composed of red blood cells, fibrin, 
platelets and other cellular elements 
Tracheal intubation Placement of a tube into the trachea for purposes of 
ventilation, airway maintenance or administering 
anaesthesia 
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1 Introduction 
1.1 Background 
Historically, the research and development of medical devices has had the main 
aim of assisting people in need of medical care. Medical devices are often 
technically complex and are highly regulated, and therefore require a lot of 
resources to be produced and maintained. Today, other constraints are being 
placed on medical devices due to economic and logistical contextual moulds, such 
as the cost of medical devices, training of the persons operating the devices and a 
high degree of safety required for the patient. Therefore innovative solutions are 
needed to address these unique problems faced. This is done with the hope that 
such devices will be able to achieve the aim of providing medical care in 
previously unexplored applications. In clinical situations, most medical devices 
are used to facilitate the medical team in providing the best possible medical care.  
 
In most surgical procedures and critical care wards, oxygen delivery to the patient 
is of utmost importance. Without adequate oxygen delivery necrosis can occur, 
nullifying other attempts at life support. Conventional oxygen delivery devices are 
well-established and have been researched to a large degree. They have ranged 
from Screen-type oxygenators, to Bubble as well as Membrane oxygenators. 
Membrane oxygenators have been implemented to oxygenate the blood while it is 
still inside the body, or pumping the blood outside the body and oxygenating it 
before returning the blood to the patient. Extracorporeal Membrane Oxygenators 
(ECMO) are widely used in clinical settings, and are regarded as the norm for 
oxygenating human blood due to the increased safety and reliability compared to 
previous oxygenators. ECMO devices do however remain costly, are large or 
immobile (not allowing ambulatory use), and require an appreciable preparation 
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time before use. Iwahashi et al. (2004) stated that a small non-pulsatile 
oxygenator is needed which is available for immediate use by the surgeon in the 
operating theatre or in first aid situations.  
1.2 Motivation 
A person in a critical care situation relies on the skills of the people attending to 
them, as well as the efficacy of the medical devices being used when they are 
being attended to. Supplying oxygen to such a person may be hampered due to the 
limited availability of a breathing support device, as can happen during a sporting 
accident. However, the supply of oxygen is often limited due to a physiological 
phenomenon. This may be due to a mechanical blockage such as when a swimmer 
drowns and has fluid in their lungs or an obstacle to tracheal intubation, such as a 
tracheal tumour. Other scenarios include damage to the fragile alveoli due to hot 
or toxic gases being drawn into lungs, or due to other effects that obstruct 
oxygenation, of which neonates are particularly susceptible. Specific cases are the 
occurrence of disorders almost exclusive to preterm neonates, such as Meconium 
Aspiration Syndrome (MAS), Respiratory Distress Syndrome (RDS) and 
Persistent Pulmonary Hypertension of the Newborn (PPHN) (Carey & Colby 
2009). PPHN is characterised by high pulmonary vascular resistance, resulting in 
the shunting of pulmonary blood to the systemic circulation. In effect, the blood is 
not fed into the pulmonary bed in the lungs, but passes via an extrapulmonary 
pathway without being oxygenated, and causes systemic arterial hypoxemia 
(Steinhorn 2011). Mortality rates can be as high as 30 % (O’Rourke et al. 1989), 
and necessitates that the patient’s blood be oxygenated apart from the lungs 
(Thakkar et al. 2001).  
 
A method of providing breathing support independent of the lungs using 
respiratory devices or artificial lungs in place of mechanical ventilators, has 
tremendous clinical potential which as of yet has not been realized (Kaar et al. 
2007). Conventional mechanical ventilation could damage the lungs even further 
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by positive airway pressure (Schubert et al. 2003), and does not address the case 
of inability of the lungs to be perfused. Modern artificial systems such as 
membrane oxygenators indirectly expose the blood to oxygen by use of a 
membrane, thereby allowing the partial pressure of oxygen in the blood to 
increase due to passive diffusion. These oxygenators have limitations on efficacy 
and ease of implementation. Clotting does occur on the membrane surface, 
reducing the rate of diffusion, and the patient needs to be monitored by a trained 
specialist at all times (Conrad et al. 1994; Frenckner & Radell 2008). 
Consequently a device that can oxygenate the blood independent of the lungs, that 
is simple to use and mobile enough to use outside of the clinical setting, could be 
very beneficial. If such a device sufficiently oxygenates the blood, it may allow 
addressing cases which mechanical ventilation cannot (such as MAS and PPHN). 
If the device is inexpensive and simple to use, it can find application in areas 
outside the hospital and clinics or in areas where ECMOs cannot be afforded. This 
may allow the treatment of cases that are currently not addressed and allow a 
larger proportion of patients that require blood oxygenation to be assisted.  
1.3 Objectives 
The concept of intravenously oxygenating the blood through microbubbles 
originated from research conducted by Prof Pieter R. Fourie (Private Paediatrician 
and Biomedical Engineer) and Prof Andre R. Coetzee (Executive Head, 
Anaesthesiology and Critical Care, Faculty of Health Sciences, Stellenbosch 
University). This research has led to the initiation of a project with the Biomedical 
Engineering Research Group (BERG) at Stellenbosch University. The present 
work relates to investigating the concept of oxygenating the blood through 
microbubbles, as well as all developmental aspects in producing an intravenous 
oxygenator.  
 
There are many concerns regarding the introduction of microbubbles into the 
blood, but it is required to know whether the blood in a human can be oxygenated 
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using microbubbles, and to what degree oxygen transfer can take place. The 
concerns are mainly due to the risk of bubbles causing embolisms, reducing the 
blood flow to certain tissues which can lead to necrosis. It is thus necessary to 
make the bubbles smaller than a certain threshold to ensure dissolution before 
reaching the capillaries of the lungs and the brain. If the blood is oxygenated by 
the presence of microbubbles in the blood, it is beneficial towards the 
development of an oxygenator to determine the rate at which oxygenation can 
take place, and how this compares to the basal requirements of an adult (roughly 
250 ml O2/min). The factors influencing oxygen transfer are to be identified as 
well as how these relate to the design of the device.  
 
Previous research has shown large difficulty in producing a prototype that is easy 
to implement, as large amounts of bleeding have occurred with other intravenous 
devices (Conrad et al. 1994; Snyder et al. 2006). In light of this, and the unknown 
oxygen transfer rate by the introduction of bubbles into the bloodstream, it is 
necessary to investigate the feasibility of a device that can be inserted 
intravenously, and determine the constraints on the size and the shape  there might 
be on the design of such a device. These objectives can be summarised into a few 
research questions: 
 
 Can the blood be sufficiently oxygenated by microbubbles? 
 Do the bubbles cause damage to the patient?  
 What effects can be observed? 
 Can a device be made that is the appropriate size for intravenous 
purposes? 
 Can such a device be inserted safely? 
 What is the approximate bubble dissolution time? 
 
The outcome of this thesis will be to have a better understanding of whether it is 
possible to intravenously oxygenate the blood using microbubbles. To have a 
better indication if the objectives have been achieved, the specific requirements 
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need to be determined for the design of the device. Size constraints on the 
prototype to be inserted into the femoral vein or the jugular vein so that bleeding 
is minimised are to be investigated. The ultimate measure of success within the 
context of this thesis would be if animal studies show that an animal’s oxygen 
requirements can be supplied by the oxygenator, and that the animal can be 
sustained such that SaO2 levels are acceptable. 
1.4 Scope 
In order to achieve the objectives as laid out previously, an understanding is 
necessary of how oxygen normally enters the blood, and how the rate of 
oxygenation can be quantified. In order to obtain a better understanding of the 
problem, this has been included together with an overview of previous research 
involving blood oxygenators in Chapter 2. How the oxygenators introduce oxygen 
into the blood stream is mentioned, and some advantages and disadvantages of 
such devices are highlighted. Concerns regarding the introduction of bubbles into 
the blood are discussed, to what degree these are important for the oxygenation of 
blood by microbubbles and why they may be more or less prominent for this 
study. Expected dissolution times are investigated and the implications to an 
intravenous bubble oxygenator are discussed. The factors affecting the formation 
of bubbles in the blood are also discussed in Chapter 2. 
 
The outline gained by the literature review in Chapter 2 gives the context for 
which the intravenous oxygenator is to be designed, and allows the design 
specifications to be articulated more accurately. The discussion regarding the 
design of the device in Chapter 3 includes the mechanism of operation, as well as 
the geometry of some concepts and their respective advantages and disadvantages. 
The selection of materials and production of a prototype is also included herein, 
explaining the thought process followed in working towards a prototype that can 
be tested with animals. The classification of an intravenous device regarding 
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biocompatibility is also considered, indicating steps required to assess the 
biocompatibility if the device is to be introduced into the medical market. 
 
To address many of the objectives laid out previously, a large part of this thesis 
revolved around the testing of prototypes by using animal models, both 
intravenous as well as extracorporeal (Chapter 4). The testing would give a 
broader indication of the efficacy of oxygenating the blood using microbubbles, as 
well as indicate the dangers of large bubbles. To assess the rate of oxygen 
delivery a flow meter was made and calibrated to be used during the animal tests. 
Chapter 5 shows the mathematical model developed to validate the findings in the 
animal tests. Conclusions and recommendations are presented in Chapter 6. 
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2 Literature Review 
2.1 Introduction 
Successful development and testing of an intravenous device requires a thorough 
understanding of the factors that influence oxygenation in human beings. A keen 
grasp of current methods allows the motivation of the project to be understood in 
greater depth, and also allows knowledge to be gained with respect to hindrances 
faced with previous devices. In this chapter an outline is given of the oxygen transfer 
that occurs in the lungs and how it can be quantified, which allows the factors 
influencing oxygen transfer to the blood to be investigated. Hindrances to 
oxygenation are then mentioned, as well as the current state of the art in terms of 
oxygenation, and some advantages and disadvantages of current systems that have 
sought to address problems in oxygenation.  Concerns regarding the intravenous 
introduction of bubbles into the bloodstream are discussed, as well as the dynamics 
involved in the formation of bubbles from a submerged orifice. 
2.2 Anatomy and Physiology 
In the human body oxygenation of blood occurs in the lungs. The blood acts as a 
carrier in transporting oxygen (O2) at a rate of roughly 1000 ml per minute to various 
parts of the body, as well as carbon dioxide (CO2) from the tissue back to the lungs 
to be exhaled at a rate of 200 ml per minute. Oxygen consumption (VO2) by the 
tissue is around 230 ml per minute and is affected by factors such as stress and 
exercise (Edwards Life Sciences 2002). The amount of oxygen delivered to the cells 
is a product of the amount of oxygen contained in the arterial blood (oxygen content) 
and the blood flow (cardiac output) that delivers the oxygen to the cells. 
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Figure 2-1: Pulmonary alveolus: alveoli and capillaries in the lungs (Encyclopaedia 
Britannica 2011) 
The human lung consists of millions of air sacks (alveoli) as seen in Figure 2-1, 
which combined creates a large surface area estimated at about 70 m
2
 to allow for 
maximum oxygenation. Diffusion of gases takes place across the thin alveolar 
capillary wall, which is about 1 µm thick, and creates a barrier between the liquid 
(blood) and gas phases. In this way, the red blood cells are exposed to a source of 
oxygen and a place to release carbon dioxide (Stamatialis et al. 2008). The blood 
flowing through the capillaries in the lungs are oxygenated by the influx of oxygen 
due to the concentration gradient between the oxygen in the blood and the oxygen in 
the alveoli. Oxygen movement is from regions of high partial pressure to regions of 
low partial pressure, as seen in Figure 2-2 below.  
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Figure 2-2: Partial pressures of gas within the lungs, blood and body tissue (Edwards 
Life Sciences 2002)  
The driving force for oxygen is about 13 times that of carbon dioxide, but the lung 
membrane is over 20 times more permeable to carbon dioxide than oxygen 
(Stamatialis et al. 2008). The mass diffusion is governed by Fick’s law of diffusion 
with constant diffusivity (Fischer et al. 2009). Fick’s first law is stated as: 
x
DJ




     (1) 
where J is the mass flux of oxygen;  
D is the diffusivity;  
  φ is the rate of change in concentration; and  
 x is the rate of change of the diffusion distance.  
 
Equation (1) shows how the flux is dependent on the change of concentration with 
respect to distance. Introducing the above equation with the conservation of mass it 
leads to Fick’s second Law as seen in equation (2), and indicates the rate of change 
of the concentration of the solute in the solvent due to diffusion. 
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2
2
D
t x
  
 
 
         (2) 
where the symbols have the same meaning as before, and t is time. Oxygen uptake is 
a complex process, and the haemoglobin molecule consists of four heme groups to 
which oxygen molecules can attach. Most of the oxygen is either chemically bound 
to haemoglobin (98.5%) which is governed by the Hill equation, or dissolved in the 
blood plasma (1.5%) (Fischer et al. 2009). The chemical binding occurs quickly, and 
is also reversible, which allows the oxygen to be bound to the red blood cells in the 
lungs, and released in the tissues with ease. The oxygenated blood is transported to 
tissue via arterial pathways, and returns via venous pathways.  
 
The plasma of oxygenated (arterial) blood usually contains 0.3/100 ml, and when 
exposed to tissue fluid which contains 0.13 ml per 100 ml of blood, diffusion occurs 
to achieve equilibrium. Because of the high concentration of oxygen bound to 
haemoglobin within the red blood cell, 100 ml of blood can supply 5 ml of oxygen to 
the tissue (Iwahashi et al. 2004).  
 
The carbon dioxide that is then produced due to the metabolic process diffuses into 
the blood, and bonds to the haemoglobin, diffuses into the plasma or is resident in the 
plasma in the form of bicarbonate (70 %). Carbonic anhydrase acts as a catalyst to 
hydrate the carbon dioxide to form bicarbonate. This is then transported back to the 
lungs to be exhaled and fresh air to be inhaled. In the case of lung trauma or 
physiological reasons as described in Section 1.2, the blood is not perfused to supply 
the needs of the patient and some or all of the blood is shunted.  
2.3 Quantifying Oxygenation 
Perfusion is defined as the passage of fluid through blood vessels or tissue, or more 
specifically the movement of blood to supply oxygen to tissues or organs and remove 
carbon dioxide. Quantifying the perfusion allows one to understand the effects of 
different factors, and to know the efficacy of the attempt at oxygenation. 
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Physiological factors such as oxygen saturation (SO2), cardiac output (CO) and 
Haemoglobin concentration (Hb) allow the oxygen delivery and consumption to be 
evaluated.  
 
SO2 is the measurement of how much oxygen is bound to the available haemoglobin, 
of which the saturation of oxygen in arterial blood (SaO2) is typically 98 %. SvO2 is 
referred to as the saturation of oxygen in mixed venous blood, due to the fact that the 
value is best measured inside the right atrium and is the average value of the blood 
returning from various tissues. Typical values are 75 %, but can be in the 60-80 % 
range (Edwards Life Sciences 2002). SO2 is expressed as a ratio of the amount of 
haemoglobin that has oxygen bound to it per total amount of haemoglobin available 
in the blood (Edwards Life Sciences 2002), and can be expressed as: 
   2
2
2
100
HbO
SO
Hb HbO
 

     (3) 
where HbO2 is the haemoglobin-bound oxygen; and 
  Hb is the amount of haemoglobin in the blood (typically 15 g/100 ml blood). 
 
The saturation of blood is dependent largely on the partial pressure (PO2) of oxygen 
in the blood, although SO2 is not a linear function of PO2. This relationship can best 
be described by the oxyhaemoglobin dissociation curve which relates PO2 to SO2, as 
seen in Figure 2-3. 
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Figure 2-3: Oxyhaemoglobin dissociation curve (Edwards Life Sciences 2002)  
This curve can be separated into two regions describing different conditions. The 
central region describes the conditions found in mixed venous blood (PṽO2), whereas 
the upper right region describes the arterial blood conditions (PaO2). As can be seen 
for venous blood conditions, a small change in the PO2 in venous blood will have a 
large effect on the SvO2. For arterial blood, however, a large change in the PO2 will 
have a small effect on the SO2, where the blood reaches fully saturated conditions. 
The affinity of Hb for oxygen is affected by several factors, one of which is the pH 
of blood. An increase in hydrogen ion concentration, for example due to respiratory 
acidosis (a build-up of carbon dioxide in the blood) causes a decrease in 
haemoglobin-oxygen affinity, shifting the oxy-haemoglobin curve to the right 
(Edwards Life Sciences 2002; Stamatialis et al. 2008). A higher PO2 is then needed 
to cause the same value of SO2 (Edwards Life Sciences 2002).  
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In order to provide an adequate amount of oxygen to the patient the oxygen 
requirements need to be known. This can be determined from equation (4) which 
describes the venous oxygen content of the blood (CvO2). The CvO2 is the amount of 
oxygen contained per 100 ml of blood and is the sum of the amount bound to the 
haemoglobin as well as the amount dissolved in plasma (Edwards Life Sciences 
2002). The uptake of oxygen by the blood is balanced with the consumption of 
oxygen by the tissues through metabolic processes.  
              2 2 21.38 0.0031CvO Hb SvO PvO         (4) 
where 1.38 is the amount of oxygen (in ml) that can be bound by 1 g of haemoglobin, 
and 0.0031 indicates the solubility of oxygen in the blood plasma. The amount of 
oxygen that the tissue consumes (VO2) is difficult to measure directly; instead the 
best indicator is the amount of oxygen that is extracted from the blood by the tissue. 
This is calculated based in the saturation values in the arterial and venous blood as 
shown in equation (5) 
     2 2 21.38   VO CO Hb SaO SvO        (5) 
where CO is the Cardiac Output. 
2.4 Current State of the Art 
Traditionally oxygenators have been used as life support devices in operating 
theatres, thus specific requirements regarding the needs of the patient in critical 
conditions have led to the designs in use today. Mechanical ventilators have been 
known to cause damage to lungs by over pressurising the lung tissue (barotrauma) as 
well as over distending the lungs (volutrauma) (Kaar et al. 2007).  In view of this, 
many different designs and approaches have been employed in the past few decades 
in the pursuit of an artificial oxygenator (Iwahashi et al. 2004) and (Haworth 2003).  
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In this pursuit, both in the form of an extracorporeal device (external) or intravenous 
device (internal), the objective is to mimic the human lung. It is not possible to 
exactly replicate the thin alveolar wall that exists in the lung, but methods have been 
employed that at least perform the action of adequately oxygenating the blood. Of 
the different methods employed, they can be classified depending on the type of 
interface formed between the oxygen source and the blood.  
 
Since the 1950’s the methods that have been implemented ranged from bubble to 
screen/film oxygenators, and finally the implementation of hollow fibre membranes 
(Iwahashi et al. 2004; Haworth 2003), but have mostly been limited to membrane 
and bubble oxygenators (Stamatialis et al. 2008; Liddicoat et al. 1974; Leonard 
2003). Membrane blood oxygenators are viewed to be safer  (Hakoshima et al. 1989; 
Masters 1989), and are therefore more widely used (Liddicoat et al. 1974). The work 
done in the field of oxygenators can be separated into classes, depicted in Figure 2-4. 
The types that are noteworthy will be discussed in the sections that follow.  
 
 
Figure 2-4: Types of oxygenators 
The most common type has been the Extracorporeal Membrane Oxygenators 
(ECMO), which is discussed in more detail in Section 2.5.1. In all cases of 
 Blood 
Oxygenators 
 Membrane 
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 Novalung 
 Intravenous 
 IVOX 
 Hattler Catheter 
 Bubble 
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oxygenator designs, efficient oxygen transfer is limited by the blood film between 
the oxygen exchange surface and deoxygenated red blood cells. Effective mixing can 
minimise the thickness of this layer, reducing the distance that the gas needs to 
diffuse (Iwahashi et al. 2004). Efficacy of an oxygenator is determined by the 
following criteria (Stamatialis et al. 2008): 
 
 The device must be able to oxygenate up to 5 l/min of venous blood to 95-
100 % haemoglobin saturation. 
 Carbon dioxide removal such that normal levels are attained (see Figure 
2-2), reducing the risk of removing too little (acidosis) or too much 
(alkalosis) carbon dioxide.  
 Have a small blood priming volume. 
 Not unnecessarily damage the blood, and avoid haemolysis and protein 
denaturation. 
 Be easy and safe to use by the person administering oxygenation, as well as 
sterile. 
2.5 Membrane Oxygenators 
Membrane oxygenators are characterised by the oxygenation taking place due to 
passive diffusion across the membrane material. The diffusion is limited by the 
membrane thickness, porosity to certain mediums, and is determined by the 
concentration gradient per unit area of the membrane. In the human body, 
membranes are manufactured from organic materials, but there is no limit to the 
nature of the barrier for use in various industries, as metal, plastic or even ceramic 
membranes can be produced (Yasuda & Lin 2003). Microporous membranes have 
dominated the market for use in oxygenators, often in the form of hydrophobic 
hollow fibres which offer increased surface area (Leonard 2003; Eash et al. 2004). 
The hollow fibres are mostly grouped as bundles, or form a cross-flow mesh as seen 
in Figure 2-5. 
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Figure 2-5: Hollow fibres (Wickramasinghe & Han 2005) 
The membrane acts as a barrier, separating the gas and liquid phases and prevents the 
blood from coming into direct contact with the oxygen. The blood plasma that is in 
contact with the membrane can have high concentrations of oxygen due to the 
diffusion into the fluid, which implies that the efficiency can be limited due to the 
lack of gradient across the membrane (Leonard 2003; Iwahashi et al. 2004). For this 
reason high blood flow rates need to be maintained in order to facilitate the mixing of 
the blood, and hence increase mass transport of oxygen into the blood as well as 
carbon dioxide removal. This increases mechanical agitation of both oxygenated as 
well as unoxygenated red blood cells, and can cause mechanical stress and damage 
(Yasuda & Lin 2003; Hakoshima et al. 1989). The interface created by the 
membrane implies that haemolysis levels are generally lower than with other 
oxygenators (Iwahashi et al. 2004). The blood is also exposed to a larger foreign 
matter surface area, especially increasing the need for biocompatible coatings of the 
hollow fibres if long term blood oxygenation is required.  
Stellenbosch University  http://scholar.sun.ac.za
17 
2.5.1 Extracorporeal 
2.5.1.1 Extracorporeal Membrane Oxygenators 
Extracorporeal Membrane Oxygenators often work on the principle that blood is 
drained from a major vein, after which the oxygenated blood is returned to a major 
artery (veno-arterial ECMO), or a major vein (veno-venous ECMO). When the 
patient is a small child it is placed close to the aortic arch as these vessels are 
generally the largest extra thoracic objects. The femoral artery is often used in older 
children (Frenckner & Radell 2008).  
 
 
Figure 2-6: Schematic drawing of a standard ECMO circuit (Frenckner & Radell 
2008) 
After the blood is withdrawn from the patient, it is drained to a collapsible bladder. 
Heparin and other fluids are then added to the blood before the blood is pumped 
through the oxygenator and heat exchanger. The addition of substances to the blood, 
as well as the complexity of machinery, requires that trained personnel need to be 
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present at all times (Conrad et al. 1994; Frenckner & Radell 2008). In the research 
done by Frenckner and Radell (2008), it was noted that as many as 21500 neonates 
have been treated with ECMO, with an overall survival to discharge of 76 % (Petrou 
et al. 2006). The survival success of patients is often predicted by observing common 
indicators such as A-aDO2, PO2 as well as the Oxygenation Index (OI). The OI is a 
function of the Mean Airway Pressure (MAP), inspired oxygen concentration and 
PaO2, where an OI value higher than 40 has been shown to predict a mortality rate 
exceeding 80 % (Frenckner & Radell 2008).  
 
One of the major disadvantages of ECMO’s is the high initial cost, as well as the 
high continuous running costs. In an interview with Murdoch Thomson (a perfusion 
technologist at Tygerberg Hospital), some light was shed on the typical 
considerations when using an ECMO. In South African terms, initial costs of the 
heart-lung bypass machines are a few million Rand, while tubing sets and calibration 
expendables cost over R 7 000 per patient (Thomson 2011). Lead times before 
oxygenation can take place are roughly one hour, where the majority of the time is 
spent anaesthetising the patient and preparing the chest cavity for the insertion and 
removal points for the blood. After this has been completed the preparation of the 
oxygenator can take place, which usually takes 12-20 minutes. Systemic 
heparinisation is initiated to prevent the blood from clotting, but can cause 
uncontrolled internal bleeding. Tubing and oxygenator kits which have been 
heparinised are available, but the cost of such kits is more than double that of normal 
kits, and essentially halves the amount of patients that can be treated due to available 
funds. The high cost is a large disadvantage in countries where resources are limited. 
 
In a large study done by Petrou et al. (2006) it was found that the average health 
service costs of neonates in the first seven years of treatment were roughly £ 30 000 
(R 450 000), almost three times that of treatment via conventional methods. The 
policies implemented in this study showed a decrease in death and severe disability 
(36.6 % of 93 cases) when using ECMO compared with conventional methods 
(58.7 % of 92 cases), but patients spent on average almost double the amount of time 
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in hospital when ECMO was implemented. Although these figures are 
overwhelmingly in favour of the use of ECMO for neonates, the situation is not so 
certain for adult patients, and is highly dependent on the specific disease or 
syndrome being treated (Crow et al. 2009). Recently, survival rates of adult patients 
have been shown to have improved, with a particular case showing survival rates for 
severe Acute Respiratory Distress Syndrome (ARDS) to be as high as 52 %. 
Although the cost and risk to the patient have been extensively analysed, ECMO 
devices remain complex and expensive machines (Kim et al. 2006; Thomson 2011). 
2.5.1.2 Novalung 
Strictly speaking, the Novalung is a paracorporeal artificial lung, using the heart to 
pump the blood through the membrane oxygenation section, and hence places extra 
strain on the heart. This is a concern for cases where neonates are being treated, or 
where the patient is already in a critical condition. The oxygenator has been 
implemented in parallel, where the blood in shunted from the pulmonary artery to the 
left atrium, but this increases the risk of thrombosis and oxygen emboli. It has also 
been implemented in series as seen in Figure 2-7. 
 
Figure 2-7: Image of the Novalung (Artificial Lungs 2010) 
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Although this is less risky than the parallel case, there is an increase in the strain 
placed on the heart. Gas transfers can be improved if larger than the current 1.3 m
2
 
membrane surface areas are used (Camboni et al. 2009). This device is one of the 
first commercially available devices that is ready for ambulatory use, although the 
elevation of the device above the patient is important, as a negative pressure can 
cause the formation of bubbles (Schmid et al. 2008). 
2.5.2 Intravenous 
Intravenous oxygenators have been used as complementary methods of supplying 
oxygen in conjunction with mechanical systems. These devices incur similar 
physiological interactions compared to the extracorporeal devices, although the 
insertion of a relatively large device intravenously is more complex. Also, the risk of 
gaseous emboli or detachment of a thrombus is increased because the device now sits 
entirely within the body, which is the case with the Hattler Catheter as shown in 
Figure 2-8. Consideration needs to be given to the following: 
 
 The presence of bubbles or foam in the blood stream. 
 Lacerations, tears or cuts in the arteries during insertion and operation. 
 Obstruction of the blood returning to the heart due to occupation of the 
vena cava. 
 
Figure 2-8: Drawing of the Hattler Catheter device as positioned in the vena cava 
(Hattler et al. 2002) 
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2.5.2.1 IVOX 
The IVOX device is inserted similar to the Hattler Catheter. It consists of crimped 
hollow fibres that are curled up into a compact bundle before it is inserted into the 
venae cava (as seen in Figure 2-9). This gas inlet is connected to a 100 % oxygen 
supply at atmospheric pressure, and the gas outlet line is connected to a vacuum 
pump. 
 
 
Figure 2-9: Photograph of the IVOX device (Mortensen 1992) 
The summary of the clinically relevant findings by Conrad et al. (1994) show 
favourable results concerning the support given through implementation of 
intravenous oxygenation methods, but maximum oxygen transfer rates were found to 
be 70 ml/min. Although this represents only about 30 % of the total requirements of 
an adult, the PO2 levels were increased above the critical 60 mmHg mark within the 
first eight hours of implementation (Conrad et al. 1994). One of the biggest problems 
faced with the IVOX is bleeding at the insertion site due to insertion and removal. In 
the above-mentioned study, blood loss due to IVOX implantation averaged 376 ml 
and IVOX removal averaged 175 ml per patient. In one particular study, 
implantations resulted in blood loss in excess of 500 ml in 15.9 % of the 164 reported 
cases. Most of the clinical trial investigators were pleased with the IVOX device, but 
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suggested that the device should transfer more gas, be easier to implant and to 
remove and be able to be utilised without the need of systemic coagulation.  
2.5.2.2 Hattler Catheter 
The aim of the research done by Eash et al. (2005) was to develop a RAC that could 
provide sufficient gas exchange such that ventilator support could be minimised, 
named the Hattler Catheter. What makes this device different from the IVOX is that 
a pulsating balloon assists in the movement of blood across the gas exchange 
membranes (Snyder et al. 2006). The device is positioned similar to the IVOX. 
Placement of the device next to the right atrium has the advantage of the gas 
exchange fibres coming into contact with blood entering the right atrium from the 
upper half of the body as well, showing notable improvements of carbon dioxide 
exchange. The pulsating balloon allows for the blood to be exposed to a larger 
membrane surface area, and therefore increases the mass transfer (Snyder et al. 
2006). Due to the increased mass transfer capabilities, surface areas of 0.17 m
2
 have 
been achieved, but the pulsating balloon has been shown to increase mass transfer in 
the length where the balloon operates. Target transfer rates of 75-85 ml/min were not 
reached with early designs, but designs changes were made to increase fluid 
velocities past the hollow fibres (Eash et al. 2005). This would have the effect of 
increasing mechanical agitation of the blood, and thus cause a larger amount of 
haemolysis.  
2.6 Bubble Oxygenators - Extracorporeal 
Between 1950 and 1980 the most commonly used oxygenator was the disposable 
bubble oxygenator. It was popular due to its low cost and ease of implementation 
(Iwahashi et al. 2004) as well as good heat and mass transfer rates (Kazakis et al. 
2008b). Many third-world countries are advocating the return to older methods such 
as bubble oxygenation due to their simplicity, and that the oxygenators can be 
manufactured easily (Leonard 2003). The production of bubbles in oxygenators can 
be produced in several ways, producing complex multiphase flows through which 
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oxygen is introduced and carbon dioxide is removed (Kazakis et al. 2008b). Oxygen 
bubbles can be produced through orifices in a plate or formation through a nozzle, 
but unintended formation can occur in membrane oxygenators by cavitation and 
boiling (Corchero et al. 2006). The most common type of bubble oxygenators consist 
of a vertical column of blood in which the gas bubbles are directly introduced, where 
buoyancy forces cause high bubble speeds. Thus large amounts of turbulence causes 
the saturated boundary layer to be minimised (Yang et al. 1971b). This increases red 
blood cell contact and causes the bubbles to dissolute faster, making the process very 
simple, yet efficient (Iwahashi et al. 2004).   
 
The main drawbacks regarding bubble oxygenators are red blood cell mechanical 
damage, as well as contact with a new foreign surface and the need to remove 
bubbles before re-entering the patient. The production of bubbles causes the blood to 
continually be exposed to new surfaces, unlike the stationary interface as found in 
membrane oxygenators (Leonard 2003). Antifoam is used to remove the froth that 
forms due to the bubbling action (Litwak 2002), but has been shown to have negative 
consequences, such as possible carcinogenicity (Thomson 2011) and an emobli from 
the antifoam itself (Cassie et al. 1960). 
2.7 Concerns Regarding Microbubbles in the Blood 
Although the introduction of microbubbles into the bloodstream may be intentional 
such as the formation of microbubbles for ultrasound imaging, it may also be 
introduced unintentionally by mechanical heart valves (Fischer et al. 2009). The 
introduction of microbubbles into the blood is a major concern as they are known to 
have negative effects. Microbubbles cause haemolysis and denature proteins in the 
blood due to the mechanical action of the microbubbles on the blood cells, but can 
also be a factor leading to tissue damage. Further investigation shows why these 
concerns are applicable to an intravenous oxygenator, and what physiological effects 
can be expected. 
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Physical forces such as shear stresses are thought to play a major role in haemolysis. 
Damage of red blood cells can be due to solid surface interaction, damage at the 
gas/blood interface, cell/cell interaction and viscous heating (Leverett et al. 1972).  
Significant haemolysis can take place in the gas/blood region, but it is considered 
that high shear stress levels causes damage, which is due to the shear stress acting 
directly on the cells (Leverett et al. 1972).  Regarding the physical size of the 
bubbles, they must be small enough so that they dissolve quickly, not obstruct blood 
flow, and not coalesce with other bubbles upon formation (Schubert et al. 2003). It is 
the relatively high surface tension of the blood-air interface that causes bubbles to be 
trapped in small vessels, and causes mechanical obstruction of the blood flow (Misra 
& Gadhinglajkar 2009; van Blankenstein et al. 1997). Bubble entrapment has been 
characterised by three factors: blood pressure, diameter of the vessels in which the 
bubbles are trapped, and surface tension of the gas-bubble interface (van 
Blankenstein et al. 1997). This implies that small capillaries as found in the brain and 
lungs are especially susceptible to the entrainment of microbubbles. 
 
Another concern is that of the introduction of pure oxygen into the blood stream, as it 
is generally considered to be toxic.  Oxygen toxicity is dependent on exposure time 
and oxygen concentration, but can be aggravated by high levels of carbon dioxide, 
stress and fatigue. It manifests as Central Nervous System toxicity – known as the 
Bert effect – which includes progressive but reversible myopia and delayed cataract 
formation (Patel et al. 2003). It can also cause pulmonary damage in which case it is 
known as the Lorraine effect. Retinopathy of Prematurity is one of the largest causes 
of blindness during childhood, and is mostly due to uncontrolled administration of 
high concentrations of oxygen (Patel et al. 2003). Premature and weak neonates are 
at higher risk and are more prone to develop chronic lung diseases due to oxygen 
toxicity (Patel et al. 2003). Pure oxygen (100 %) can be tolerated at sea level 
pressure for 24-48 hours, but thereafter tissue damage will occur (Patel et al. 2003). 
Thus there is a possibility that the advantages of short-term implementation of an 
intravenous bubble oxygenator may outweigh the risks such as haemolysis and 
oxygen toxicity.  
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2.8 Bubble Dynamics 
2.8.1 Force Balance 
The formation of bubbles in multiphase flows is dependent on different factors of the 
phases, where a force balance indicates the effects of different properties. The 
formation of bubbles from a pore can be classified into four stages: nucleation 
period, under-critical growth, critical growth and necking (Gnyloskurenko et al. 
2003). When necking is complete, the bubble detaches, and becomes free of the 
surface effects found along the membrane surface. The different stages can be seen 
in Figure 2-10, showing the effects on bubble formation of a surface with good 
wettability, compared to one with poor wettability. It can already be seen what 
effects wettability has on bubble formation. 
 
 
Figure 2-10: Bubble formation stages: (a) Good wettability, (b) Poor wettability 
(Gnyloskurenko et al. 2003) 
Investigating the forces acting on the bubble reveals that forces act either to detach 
the bubbles, or to resist detachment. Detachment forces on the bubble are gas 
momentum, gas pressure force and tangential viscous drag, while retardation forces 
are the parallel viscous drag working in the axial direction of the pore, inertial force 
of the liquid and surface tension forces (Kazakis et al. 2008b), (Nahra & Kamotani 
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1998), (Krishnan 1994). Buoyancy may act to detach the bubble or to retard its 
detachment, depending on the orientation of the device. Figure 2-11 depicts the 
forces and the line of action. 
 
Figure 2-11: Force balance of a bubble during the critical growth period 
2.8.2 Effect of Material Properties 
For bubble formation to occur from a submerged orifice the capillary pressure needs 
to be overcome. The pressure is inversely proportional to the capillary diameter, 
which is known as the bubble point pressure, and gives an indication of the pore 
sizes of the material. After this pressure is overcome and a bubble starts to form, the 
bubble grows to such a point that it detaches from the pore. The capillary pressure is 
given by (Kazakis et al. 2008b): 
 
2
 L
p
p
r

       (6) 
where    is the surface tension; 
           is the pore radius; and 
              is the capillary pressure. 
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Apart from haemocompatibility, the material properties affect the bubble production 
based on wettability, as well as pore size  (Gnyloskurenko et al. 2003). Smaller pores 
form more numerous, smaller bubbles (Kazakis et al. 2008b). There are two distinct 
regions that exist, as seen in Figure 2-11, that of the gas/liquid (blood) where the 
bubble is formed and one of the membrane/liquid where there are no pores. The first 
is dominated by viscosity and surface tension effects, whereas the second is 
dominated by surface tension and polarity of the liquid and polymer surface. The 
bubble that is formed at the pore does not extend its base further than the pore edges 
when a hydrophilic (good wettability) material is used (Corchero et al. 2006; Martin 
et al. 2006), as seen in Figure 2-10, but reaches final size when other forces such as 
buoyancy or drag cause the bubble to detach. 
 
The material properties affect the bubble size based on the fact that surfaces with 
higher energy are more hydrophilic, and are therefore characterised by smaller water 
contact angles (in the 0 < θ ˂ π/2 range). In effect, the surface is electrically polarised 
which allows polar fluids such as water (and therefore also blood) to form hydrogen 
bonds with the surface. Research shows that for very hydrophilic surfaces below the 
θ = π/4 cross-over angle (see Figure 2-11), bubble size is a function of the size of the 
orifice only, and not the contact angle (Yasuda & Lin 2003; Gnyloskurenko et al. 
2003) as illustrated in Figure 2-12. This implies that if a material is chosen with high 
wettability, i.e. small contact angle, that the pore size can be minimised which will 
minimise the bubble volume, and hence increase the surface-to-volume ratio of the 
bubble introduced into the blood. The surface-to-volume ratio is an indication of the 
size of the bubbles, where a larger ratio is advantageous for bubbles in the blood as 
this implies a larger surface area for oxygen transfer.  
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Figure 2-12: Graph of bubble surface-to-volume ratio vs. water contact angle  
(Yasuda & Lin 2003) 
For larger contact angles (0 < π/2 < π), the surface is hydrophobic, and has low 
surface energy (Yasuda & Lin 2003). In this range, bubbles size is independent of the 
pore size, but is rather dependent on the surface energy of the submerged surface. On 
a very hydrophobic surface the base of the bubble can be up to 10 times the diameter 
of the orifice (Yasuda & Lin 2003). Surfaces which exhibit lower contact angles 
allow the bubble size to be determined by the pore size, allowing bubble sizes to be 
minimised.  
2.8.3 Effects of Fluid Properties 
The liquid that the bubbles is being formed into plays a large role in terms of bubble 
formation and bubble movement. During growth and detachment phases, the bubbles 
may coalesce with other bubbles emanating from neighbouring formation sites to 
form a larger bubble (Kazakis et al. 2008a). The low surface tension of the blood 
may hinder coalescence of bubbles, as the thin film between neighbouring connected 
bubbles is not drawn away completely (Kazakis et al. 2008a; Tse et al. 1998). Tan et 
al. state that coalescence is minimised because viscous drag and buoyancy forces 
have the effect of removing the bubbles from the formation site, reducing the chance 
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of coalescence (Tan et al. 2000). The drifting action is more pronounced when the 
bubbles are produced in a high viscosity fluid, as buoyancy forces are negated by 
drag forces. Higher liquid viscosity increases drag, and coupled with the normal flow 
of the blood with respect to the gas flow assists to detach the bubbles from the pores. 
Kazakis et al. noted that smaller bubbles were formed in fluids with higher viscosity 
(Kazakis et al. 2008b). This is attributed to more pores being activated due to the 
normal direction force on already forming bubbles for the same gas flow rate, which 
also means that the mean bubble size is reduced, and more numerous bubbles are 
produced (Kazakis et al. 2008b). 
2.9 Summary of Chapter 
The amount of oxygen dissolution in the blood and oxygen supply rates to the tissue 
can be quantified by observing the blood saturation equations as described in 
equation (4) and (5). The SO2 of the blood is a function of PO2 as seen in the 
oxyhaemoglobin curve (Figure 2-3), which indicates that a small change in PO2 in 
venous blood can cause a large change in the SvO2. Although oxygenation devices 
have been in development for the past 60 years, there are still shortcomings with 
regards to increasing the PO2 in the blood of the patient, such as extra harm to the 
lungs, the incidence of blood trauma as well as high costs of some of the devices. 
The short-term implementation of an intravenous bubble oxygenator may however 
prove useful when considering the impracticality of larger ECMO devices, or the 
reduced oxygen transfer of respiratory assist devices such as the IVOX, Hattler 
Catheter or Novalung. The risks regarding the introduction of microbubbles into the 
blood have been highlighted, and it is noted that long-term bubble oxygenation is 
more dangerous to the patient than when membrane oxygenators are used. To 
minimise the risk presented by the bubbles, the bubble sizes need to be minimised, 
and in effect increasing the surface-to-volume ratio and hence oxygen transfer rates. 
The factors that influence bubble formation were investigated, and it was found that 
hydrophilic membranes are advantageous for the production of smaller bubbles from 
a submerged orifice as the bubble sizes are controlled by the pore sizes only.  
Stellenbosch University  http://scholar.sun.ac.za
30 
 
 
 
3 Design 
3.1 Performance Requirements 
A method of oxygenating the blood is desired that can temporarily replace the 
function of the lungs. This method must be safe, effective and easy to implement. 
A few ideas were drawn up and discussed with Prof Coetzee to obtain 
clarification regarding the implementation of such devices, as well as possible 
insertion techniques for a catheter-like design. Thereafter, a more general design 
was decided upon, which would allow the concept to be proven. Emphasis was 
placed on two main factors in order to achieve the objectives laid out in Section 
1.3 regarding the design of the device. Firstly, the selection of a material is 
considered that can be used to produce microbubbles within the blood. The 
microbubbles preferably need to be less than 300 µm to ensure adequate 
dissolution; it is however uncertain exactly what size bubbles are too large. 
Further testing will give an indication regarding bubble sizes, and what 
physiological effects can be seen that will be an indication of damage caused by 
the bubbles.  
 
Secondly, the size and geometry of the design is determined by the size of the 
femoral vein (where the device is inserted) as well as the vena cava (where the 
device is placed). The final implementation of the device needs to be such that 
bleeding is minimised while still being easy to implement. These requirements, as 
well as other requirements outlined by Prof Fourie were used to construct a list of 
specifications given in Table 3-1. 
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Table 3-1: Design Specifications 
Parameter Limits Reason 
Device Outer 
Diameter 
6 mm (18Fr) Minimise bleeding 
Insertion and 
Removal Method 
Via standard 
catheterisation 
procedures 
Equipment exists and procedures are 
safe and well established 
Oxygen Delivery 75-125 ml/min 
Represents 30-50 % of adult basal 
requirements 
Bubble Size Less than 300 µm 
Initial estimate on minimum bubble size 
required for dissolution of bubbles 
before reaching the lungs 
Internal Pressure 
High pressures - 
dependent on 
material pore size 
Material must under no circumstances 
rupture or tear as this would cause death 
of the patient  
Material Properties 
Hydrophilic, less 
than 5 µm pore 
sizes 
Smaller bubbles are produced from 
smaller pores and a hydrophilic surface 
Oxygenation 
Assistance Time 
Less than 30 
minutes 
The device is not intended for long term 
usage, but rather for short term 
intervention or assistance as a means of 
first aid 
Biocompatibility Haemocompatible 
Possibly a compatible coating on the 
device surface, but duration of 
oxygenation must be taken into account 
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3.2 Initial Concept  
The safety and ease of use of such a device is mostly attributed to its physical 
geometry and surface properties of such a device. In an email from Prof Fourie 
(2010), some criteria were outlined that the oxygenator needed to fulfil, and 
consideration was given to the design to fulfil these criteria. Intravenous 
oxygenators already exist that are inserted and operated similar to that of regular 
catheters. The concept of a RAC has several advantages, mostly concerning 
insertion and removal of the device, as well as ease of producing a prototype. 
Catheterisation of venous areas is a common procedure, and thus the testing of 
such a device could easily be implemented. The device must be easy to insert and 
to remove, and cause little bleeding to the patient, as these were issues faced with 
other RACs. It also should be sturdy and reliable, i.e. provide a constant, known 
amount of oxygen to the patient to supply 30-50 % of the patient’s oxygen 
requirements. The basic shape is shown in Figure 3-1, and includes the oxygen 
transfer section, oxygen supply tube and the insertion nipple. Different concepts 
can be seen in Table A-1 in Appendix A. These range from star-shaped cross 
sections to tangling hollow-fibres, but the final concept that was chosen is 
depicted in Figure 3-1. The oxygenation section could be up to 300 mm in length 
due to the length of vena cava, and match the diameter of the vena cava (which 
varies with age, but is roughly 25 mm). One of the requirements laid down by 
Prof Fourie (2010) was that the cross-sectional area must not obstruct more than 
50 % of the vena cava.  
 
 
Figure 3-1: Diagram of original concept 
A 
B 
C
 
 A 
D 
E F G H 
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A layout of the final concept shows that the device lies within the vein (A), while 
the blood (B) flows past the oxygenation section (C) where the bubbles are 
produced. A cross-sectional view (D) of the device being deployed can be seen in 
Figure 3-2. The insertion nipple (E) allows for the oxygenator to be guided into 
the vein without damaging the endothelium of the veins. This could typically be 
constructed of silicon. The other end of the device is connected to the oxygen 
supply tube (G) at the base of the oxygenator (F). The end of the device that is 
inserted first (E) and lies closest to the heart will henceforth be known as the 
proximal end, and the end furthest from the heart the distal end. The oxygen 
supply tube is connected via ports (H) to the oxygen supply tank, as well as to a 
pressure gauge if required. 
 
 
Figure 3-2: Cross-section of the deployment of the oxygenator 
The deployment of a folded oxygenation section would allow a larger 
oxygenation section to be exposed to the blood. The folded section (I) as seen in 
Figure 3-2 would occupy less space than the deployed section (J), and would add 
extra rigidity for inserting the device into the vein. It was noted early on that 
producing a prototype with the shape as shown in Figure 3-2, would be difficult 
due to the sealing that would be necessary along the length of the tubular 
structure, as well as at the ends of the device. The proximal end of the 
oxygenation section would be sealed around the flexible nipple, and the distal end 
would be sealed around the oxygen supply tube. This could be achieved through a 
Nylon insert, but would add volume and complexity without an increase in seal 
quality. The supply tube could also temporarily house the guide wire if needed 
I J 
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and remove waste gasses if needed. Prof Coetzee suggested that the device 
incorporate a static pressure transducer or a blow-off valve (at H in Figure 3-1) to 
prevent excessive pressure developing inside the device. This was not 
implemented in the prototypes but could be considered for future work. 
3.3 Geometry and Mechanics of Operation 
3.3.1 Conceptual Operation 
The initial idea for the mode of operation of the device was conceived after the 
design specifications of the oxygenator were considered. The operation depended 
on the insertion method, size constraints, as well as material properties and 
availability of materials. The decision to use a membrane material was made after 
initial research showed that polymer membranes are commonly used in 
oxygenators (Haworth 2003), and thus such materials are readily available from 
suppliers, as well as that the membranes can be coated to improve 
biocompatibility of blood contact devices. The method of bubble formation was 
investigated to obtain a better understanding regarding possible production 
methods of a prototype. Previous authors have looked into the production of 
microbubbles for introduction into the bloodstream (Schubert et al. 2003). One of 
the methods was by microetching silicon liquid and gas pathways, which allows 
the oxygen bubbles to be formed by a venturi effect when the blood flows past the 
constricting wall, as shown in Figure 3-3. This constricting wall creates a nozzle 
of high velocity against the walls to assist in formation of smaller bubbles, and 
also creates turbulence in the flow direction to facilitate mixing. 
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Figure 3-3: Venturi effect generates small oxygen bubbles in the liquid pathways      
(Sung Sam Kim & Schubert 2007) 
 
Figure 3-4: Combination of many liquid pathways to form the device to be 
inserted (Sung Sam Kim & Schubert 2007) 
As seen in Figure 3-4, many liquid pathways are microetched in a radial manner 
to create a surface where fluid and gas can flow. Blood flows from the outside of 
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the device towards the inner section and is thus oxygenated. Previous researchers 
have also aimed to produce bubbles by pulsing oxygen through a fine nozzle at 
very high frequencies (Schubert et al. 2003).  
 
Due to the risk of microbubbles damaging the tissue, consideration was given to 
include a defoamer section that would allow the bubbles to be broken down, 
removed or contained. The formation of a blood-foam facilitates oxygen transfer, 
but if it progresses without control can hamper gaseous transfer (Villavicencio & 
Warren 1962). As seen in Figure 3-5 this design would be implemented by having 
a mixing chamber (A) where the oxygen transfer effectively takes place and 
which also functions to channel the blood and thus contain the movement of 
bubbles to within this chamber (E). The mixing chamber is attached at the base 
(C) of the smaller oxygenation section (D), and the blood flow (B) is redirected to 
flow through the mixing chamber. 
 
 
Figure 3-5: Initial concept with the mixing chamber 
The mixing chamber can be manufactured from different materials, but would 
typically be of a sponge-like material or a mesh/fabric. In some cases Antifoam A 
(polymethylsiloxane) has been used, but has been shown to cause embolisms in 
the brain and kidneys (Villavicencio & Warren 1962). For the purpose of this 
thesis the defoamer section was not included due to the added complexity in the 
proof of concept tests. Additionally, animal testing would possibly reveal the 
extent to which small microbubbles could cause harm.  
B 
D
 
 A 
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E 
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3.3.2 Cross-sectional Area 
Usage of a membrane material requires that the surface properties, pore sizes and 
material strength fulfil the design specifications. The membrane sheets available 
on the market are polymers that often have the same thickness and flexibility as 
paper. The membrane material could possibly be folded into a shape that would 
optimise its exposed surface area, while decreasing its volume for easy insertion. 
The exposed surface area causes obstruction of flow that facilitates the mixing of 
the blood and oxygen bubbles. The orientation of the device within the vena cava 
would also have an impact, as this would determine the exposed surface area, as 
well flow obstruction and the facilitating of mixing and the production of smaller 
bubbles. A few conceptual cross-sections were considered and are classified 
according to the method the oxygenation section as secured to the supply tube, 
and consequently the amount of surface in contact with the blood. Examples are 
shown in Table 3-2. The advantage of cross-sections with lobes/veins is that the 
membrane can be folded to make the device smaller and stiffer for insertion, but 
upon applying a high internal pressure the device would unfurl and expose a 
larger area for bubble production. The concepts are described in the table (blue 
outlines indicate surfaces where bubbling occurs, whereas green outlines are 
support structures for the oxygenation surfaces). 
 
Table 3-2: Cross-sectional concepts 
Number Shape Description 
1 
 
This is the simplest design, but does not allow for the 
device to self-centre within the vein, and could 
possibly be unstable with respect to position within 
the vein.  
Vein 
Oxygenator 
Stellenbosch University  http://scholar.sun.ac.za
38 
 
 
 
 
 
 
 
  
 
 
  
2 
 
Four lobes increase the surface area while reducing 
the cross-sectional area being obstructed, but if the 
internal pressure is high enough the lobes will 
expand. The lobes can be folded for easy insertion, 
and can act to locate the oxygenator within the vein. 
3 
 
This concept is a slight adaptation of the above 
concept, but the lobes are attached to a central 
support structure to prevent the veins from expanding 
under higher pressures. Folding the lobes for 
insertion may also make the device easier to remove 
due to partial shape retention.  
4 
 
Upon high internal pressure the lobes expand and are 
firm enough to enable the device to centre itself 
within the vein while exposing the oxygenation 
surface to the blood flow. 
5 
 
This design differs from the previous one in that the 
blood flow is not completely external to the device, 
but there is a dedicated mixing chamber, noted by the 
green lines (as structural). The oxygenation takes 
place mainly between the blue and green sections, 
which implies that there is a reduction in surface area 
and thus oxygenation capability. The mixing chamber 
needs to be of a stiff, not necessarily porous material, 
but will again allow placement of the device within 
the vein. 
 
Some of these designs were realised by making paper models, to imitate the 
expected working condition of the oxygenator within the body. This was done to 
get a rough idea of the expansion and the rigidity of the material, which was 
similar in strength and thickness to paper, examples of which can be seen in 
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Figure A-1 and Figure A-2 in Appendix A. The paper allowed for models to be 
produced easily and different folding techniques to be explored (on a scale of 1:5), 
with the aim of finding the smallest possible folded size while not hampering 
unfurling of the device. This took into consideration the length of the veins (or 
lobes), and the outer circumference of the folded shape, which gave insight into 
limitations regarding material stiffness and minimum device sizes.  
3.3.3 Material Selection 
The selection of a membrane material to be used for the oxygenator was done in 
conjunction with simple tests to investigate the properties of different materials. 
Sample materials were obtained from a local representative of PALL Corporation, 
and were screened to investigate the bubbles emanating from a submerged orifice 
based on pore size, material type and free surface energy. Added to the concept of 
bubbling oxygen directly into the blood is the idea that the oxygenation area is no 
longer directly dependent on the device geometry and surface area, but now 
rather on the bubble surfaces. According to previous work done on intravenous 
membrane oxygenators, surface areas ranging from 0.21-0.52 m
2
 are available in 
products such as the IVOX, whereas a pulsating balloon device such as the Hattler 
Catheter could reduce the contact area with blood to about 0.17 m
2
 (Snyder et al. 
2006).  
 
Considering that the device needs to supply oxygen at the rate of 125 ml/min and 
that the exposed surface is known, the oxygen transfer per surface area per minute 
can be calculated. If the oxygenation section is 300 mm long, and the approximate 
insertion size allows for an exposed circumference of 25 mm (which is dependent 
on the concept shape and cross-sectional area), the total exposed area would be 
75 cm
2
 (7.5x10
-3
 m
2
). Comparing this to the approximate 70 m
2
 surface area that 
the lungs occupy it can be seen that very high transfer rates must be attained to 
make such a device comparable to the efficiency of the lung. This can potentially 
be achieved by increasing the surface area to volume ratio, such that more of the 
oxygen is in contact with the blood. For example, a bubble of 300 µm diameter 
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will have a surface area of 0.283 mm
2
 and a volume of 0.0141 mm
3
, or 1.4110-5 
ml. As depicted in Figure B-1 in Appendix B, a rough estimate when looking at 
some of the photos taken for glycerol tests show that roughly 400 bubbles can be 
formed (of 300 µm size diameter) per second from a surface area of 20 mm
2
 (or 
0.2 cm
2
). This yields an oxygen bubble production rate of 0.028 ml oxygen per 
second per square cm of the device.  
 
Important factors that surround the bubble size and distribution, are the 
oxygenator geometry, operating conditions (such as blood viscosity), physical 
properties of the two phases and the type of bubble producing method used 
(Kazakis et al. 2008b). For the purposes of this thesis, bubbles would be produced 
by the application of a pressure gradient across a membrane material. A set of 
initial tests were performed with the aim of determining which material could 
possibly be used as the oxygenation section. These tests were performed in 
conditions that simulated the operation of the intravenous device, but were 
simplified to a degree to which clarification could be found without 
compromising reliability. Various materials of different filters were supplied by a 
local representative of Pall Corporation and consisted of blood transfusion filters 
to air filters (more details can be seen in Table B-1 in Appendix B). The specific 
properties of the materials have been optimized for the intended use of the filter, 
the properties of which include the polymer type, pore sizes (determined by the 
bubble point method), surface energy and material strength (which is a function of 
the polymer type).  
 
The simplest test setup was to test the materials while submerged under water, to 
investigate the effect of the material type, pore size and surface energy on bubble 
production. The tests were performed under standard conditions at room 
temperature. Air was forced through the different materials under different 
pressures by use of a simple medical syringe, with the knowledge that air and 
oxygen have densities and viscosities similar enough for the purpose of these 
tests. The production of bubbles as well as the performance of the materials was 
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investigated. Test samples were prepared by cutting a circular material section 
about 15 mm in diameter and placing it over one end of 40 mm length clear tubing 
to create an exposed membrane surface area of roughly 15-20 mm
2
. Heat-shrink 
tubing was then slipped over the clear tubing and material, and heat applied to 
allow the heat-shrink to grip the material onto the clear tubing. Adhesive was used 
to fill in the gaps and ensure that the material did not slip off under gas pressures 
(Figure 3-6). It was already seen that the heat applied to some of the test samples 
damaged some of the materials, thus some samples were prepared using adhesive 
only. Initially it was observed that some materials (such as polyester) were 
sensitive to the type of adhesive used. The difference of hydrophobic and 
hydrophilic materials is shown in Figure 3-7. 
 
      
Figure 3-6: Samples for simple tests 
    
   (a)                               (b)     
Figure 3-7: (a) Hydrophobic and (b) hydrophilic material 
The samples would be manufactured by first folding the material around the clear 
plastic tubing, after which heat-shrink would be used to facilitate the forming of 
the membrane material over the opening of the tubing. The adhesive would then 
be used ensure that no gaps existed between the membrane material and the heat-
6 mm 
Clear plastic tubing 
Heat-shrink (shrunk  
and glued) 
Membrane material 
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shrink. Another layer of heat-shrink would then be used to ensure an air tight seal. 
This process was followed in making all the samples used in the simple tests; care 
was taken to ensure that heat and mechanical damage to the samples were 
mitigated.  
 
Initial observations of 11 materials (see Table B-1) indicated that smaller bubbles 
were produced by membranes with smaller pore sizes and would thus be better 
suited for the oxygenator. At higher flow rates, larger bubbles were formed at 
higher frequencies. Higher pressures were required to overcome capillary pressure 
for small pore sizes, most evident was the high pressure needed to initiate bubble 
formation from the material with the smallest pore, the positively charged Nylon 
filter with 0.2 µm pore sizes (M6 as seen in Table B-1). However, the bubbles 
were not as small as expected, as the slightly hydrophobic nature of the material 
caused coalescence of bubbles along the surface of the material. Weaknesses in 
the materials caused large bubbles to form at the damage sites, which would have 
been a cause of an enlargement of pores. This is due to the decreased amount of 
pressure needed to overcome capillary pressure. Some bubbles would continue to 
grow and coalesce until buoyancy forces caused the bubbles to detach. Materials 
M5 and M6 exhibited the most favourable bubble sizes, mostly due to the small 
pore sizes of the materials. Based on this knowledge, samples were requested 
from PALL Corporation to be used for further testing and the development of 
prototypes. Due to the long waiting periods for delivery (between 6 weeks and 4 
months) only the Nylon and PES membranes were further tested. 
 
For further analysis of the materials, a cylindrical tank was used and filled with a 
glycerol-water-saline mixture, with an equivalent surface tension and viscosity to 
that of blood (Rodriguez 2011). The glycerol mixture was based on research done 
by a previous student and a mixture was prepared by mass, consisting of 48 % 
glycerol, 52 % distilled water and 9 g salt per kg of final solution (densities can be 
found in Table C-1 in Appendix C. Sodium azide is often included in mixtures 
simulating the blood, but due to its high toxicity and difficulty of disposal 
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(specifically the highly reactivity with copper pipes) it was decided not to use this 
mixture. Approximately 11 l of mixture was prepared, with a final density of 
ρ = 1.125 kg/m3. 
 
The screened materials were used to make test samples using the same method as 
for the initial tests and the air forced through in a similar way. Different flow rates 
were investigated for the different materials and it was found that for smaller pore 
sizes the bubbles produced were smaller than with the water tests. It was also seen 
that bubble size was directly proportional to flow rate and dependent on the type 
of fluid used. The smallest bubbles that could be observed were in the 200-300 
µm range. 
3.4 Final Design Decision and Prototype 
The final design shape was decided upon based on the fact that the concept had to 
be proven to work first. The design that was simplest to manufacture and that 
could prove the concept was thus selected. The final design that was decided upon 
was achievable in the sense that the manufacturing would be done by simple yet 
effective means. Manufacturing of a prototype was problematic due to limited 
expertise and information available regarding polymer sealing methods and 
compatibility. Different companies were approached regarding the assistance of 
manufacturing a prototype but none could be of assistance, either due to lack of 
facilities or because this research falls outside of their scope of work. It was then 
decided that a prototype would be produced by manually sealing the membrane 
onto an oxygen supply tube, and possibly incorporating the insertion nipple as 
discussed earlier.  
 
Different chemical adhesives were considered to create a robust seal between the 
membrane and other structures of the oxygenator, but it was found that certain 
adhesives damaged the materials. For example, the polyethersulfone (PES) 
samples deteriorated when used in conjunction with superglue (cyanoacrylate 
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based adhesives). Also, none of the adhesives could cause the membranes to be 
attached to the silicon tubing that was considered for the oxygen supply tube to 
create a proper seal. Thus, polymer welding was considered and more specifically 
high frequency welding and ultrasonic welding, as well as heat sealing. High 
frequency welding is commonly used for polyamides such as Nylon, but due to 
the high cost to develop a single prototype heat sealing was considered.  
 
An industrial heat-sealer was obtained to seal the selected material (Nylon). Good 
seals were achieved with Nylon, but sealing onto the silicon tubing was not 
possible. A PVC catheter was next considered, but efforts to heat seal onto PVC 
catheters resulted in the catheters being damaged. The incompatibility of a silicon 
insert with the Nylon membrane did not allow the insert to be used either. The 
seal formed on the Nylon membrane was often stronger than the material on its 
own, but it was difficult to be sure that the seal was of a good quality. Seemingly 
strong seals were not as strong as expected and would easily tear upon application 
of an internal pressure. Through improving the manufacturing process it was 
found that a medium heat on one side of the folded membrane, and then a slightly 
higher temperature on the other side (both held for maximum heating time and 
pressure), would ensure a very good bond. This process was highly dependent on 
learning the heating characteristics of the impulse sealer, as well as the melting 
characteristics of the Nylon material. Interestingly, it seemed that the already 
melted Nylon would have a higher resistance to the flow of heat. Upon cooling, 
the melted and transparent material would shrink, and distort the folded shape, 
which inhibited the production of sufficiently long prototypes due to the fact that 
distortion reduced the ease with which a double-sided seal could be achieved. For 
initial prototypes as shown in Figure 3-8, a cylindrical shape was produced by 
folding a membrane sheet in half and sealing at angles of about 60˚ to the axial 
line of the device. The distal end of the device was cut to allow the insertion of the 
oxygen supply line. 
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Figure 3-8: Example of a heat sealed prototype 
A few of the prototypes were tested under water to inspect the quality of the seal. 
Some of the prototypes seemed to perform well with regards to bubble size and 
withstanding high internal pressures, but it was discovered only after the first 
animal test that the heat-sealing of the Nylon possibly damaged the material. This 
could be due to the opening of pores due to material shrinkage upon cooling, 
distorting the material near the seals. This nullified the use of a material with very 
small pores, and is believed to have been one of the complications with the in vivo 
animal test (Chapter 4). A batch of five adhesives were then further explored to 
find an adhesive that is compatible with Nylon, and this was then used to 
manufacture a prototype that was used in the ex vivo tests. The device was based 
on an embolectomy catheter, and proved to be of sufficient strength to withstand 
the internal pressures upon testing without separating. 
3.5 Biocompatibility Assessment 
Surface modifiers can be added to blood contacting devices to improve 
haemocompatibility of the devices. Improving the haemocompatibility is closely 
linked to the protein adsorption by the foreign material due to the fact that protein 
adsorption triggers the coagulation sequence. Other methods of coagulation 
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include platelet activation as well as the compliment system and tissue factors. 
Insertion and operation of the device can cause vessel trauma, which is related to 
the generation of a local positive charge and suggests that surfaces with negatively 
charged groups will exhibit good biocompatibility. Some developments do 
however show that biocompatibility can be achieved by using hydrophilic or non-
ionic surfaces, as have been implemented in this thesis. Generally, improving 
biocompatibility concerns altering the surface properties that suppress or prevent 
blood interactions, but allows the bulk of the material which displays certain 
favourable properties, to be left unchanged (Mao et al. 2004).  
 
For a device to be implemented in a clinical setting it often needs to comply with 
certain national and international standards. Although the haemocompatibility is 
not very important for the proof of concept tests for the purpose of this thesis, the 
implementation of a device within a South African context requires that it 
complies with certain standards. These standards require that the correct 
procedures for medical registration are followed which will allow the device to be 
available on the South African market. According to the Medicines and Related 
Substances Act, 1965, Act No. 101 of 1965 (2011), the intravenous oxygenator 
would fall under category C2 due to the penetration of the body by the device, and 
can be further classified as Low, Low Moderate, High Moderate or High Risk. 
According to the ISO 10993-4 Biological evaluation of medical devices – 
Selection of tests for interactions with blood, a decision tree can be followed to 
determine the tests that need to be performed to evaluate the biocompatibility of 
medical devices. The decision tree (shown in Figure D-1 in Appendix D) suggests 
that for the device being considered, ISO blood interaction tables need to be 
consulted. 
 
The ISO standards classify the type of blood contacting devices as non-contact 
devices, external communicating devices or implant devices. A device such as a 
RAC would be classified as an external communicating device and similar to a 
catheter in design, but acts as an oxygenator. The blood/device interactions can be 
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assessed according to ISO 10993-4:2002(E) and based on the type of device, 
requires that all five categories of blood interactions should be investigated, i.e. 
thrombosis, coagulation, platelets, haematology and complement system (ISO 
2002). 
 
It goes without saying that, where appropriate, a device that is intended to be used 
ex vivo is to be tested ex vivo, and similarly with a device intended to be used in 
vivo. This includes testing the device under circumstances that simulate the 
clinical applications with respect to geometry, blood contact method and time, 
temperature and blood flow conditions. Inspection of the blood interactions with a 
device of defined geometry allows the ratio of test parameter to exposed surface 
area can be evaluated, which will give an indication of total blood/device 
interaction. 
 
Animal tests were conducted with the aim of validating the design of the device, 
and investigating the blood interactions. A porcine model was used due to the 
similarities in the blood of such animals compared to that of humans, and is 
explored more in Chapter 4. During the in vivo test an anticoagulant (heparin) was 
not added immediately, but was added later due to the blockages that were 
assumed had formed in the proximal and distal ports of the Swanz-Gans catheter, 
around which the prototype was based. It was required that measurements could 
be taken of the blood to evaluate the dissolved as well as bound oxygen.     
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4 Testing of Concept 
4.1 Introduction 
Previous analysis (Chapter 3) of bubble production from a submerged orifice has 
given an indication regarding possible bubble sizes that can be produced, but 
these tests are limited to information gained regarding a device placed within the 
body (in vivo). For this thesis, using an animal model would yield a better 
understanding of the concept as the physiological environment is the same as 
would be found in a human patient. Before animal models could be used to 
investigate concepts, an application was sent in for review by the Research Ethics 
Committee: Animal Care and Use, under the title ‘Evaluating the effects of 
intravenous oxygenation on blood-gas parameters and lung pathology’. Approval 
of such a proposal allows sentient animals to be used for research, teaching and 
testing. This takes into consideration the moral philosophy of non-human animal 
tests, which includes the humane treatment of animals such that the best interest 
of the animals is a priority. Appropriate persons were responsible for the various 
aspects of the animal tests. This included the provision and proper removal of the 
animals (according to standard methods implemented by the Animal house 
Manager at the Faculty of Health Sciences) as well as the actual testing 
procedures as commonly practised.  
 
A testing protocol for the respective tests was established, which included the 
preparation of the animal model all the way through to final observations. The in 
vivo and ex vivo tests were performed in a similar manner, but the in vitro tests 
will be dealt with separately, the details of which are explained in the respective 
sections. The first step in the protocol was preparation of the animal model, which 
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included anaesthetising the animal ensuring that the animal was properly 
monitored and ventilated. This was done by the team at Tygerberg Campus of 
Stellenbosch University where the testing took place.  For the preparation of the 
ex vivo tests specifically, a circuit was set up prior to testing using standard 
medical expendables. Observations were then made regarding the condition of the 
animal in terms of physiological factors such as heart rate, SO2 and body 
temperature. The device was then placed inside the animal for the in vivo tests, 
and inside the extracorporeal circuit for the ex vivo tests. For the in vivo tests, the 
condition of the animal was again observed and noted, to investigate whether any 
physiological changes could be seen. The placement of the device within the ex 
vivo circuit was much easier than in vivo circuit due  to the size of the catheters 
used in the respective tests.  
 
The supply of oxygen was then initiated, while the flow rate of oxygen was very 
closely monitored and correlated with the physiological effects as seen in the 
animal in the in vivo test, as well as correlated with the formation of bubbles in 
the ex vivo test. The flow rate was then increased systematically and 
physiological effects and bubble formation monitored. Finally, after testing had 
been completed, the animals were euthanized and the devices were removed. 
4.2 In Vivo 
The in vivo tests were done using a porcine model to investigate the performance 
of the oxygenator under controlled conditions. This simulates the conditions of 
implementation in a human due to the similarities in the physiology between 
porcine animals and humans. This would give information regarding the rate of 
dissolution of the bubbles, as well as the physiological effect this would have on a 
biological specimen. The first prototype consisted of 5 µm pore size Nylon 
membrane attached to silicon tubing, but due to the size and insufficient sealing of 
the membrane to the silicon tubing, the prototype was not used. A second 
prototype was based on a Swan-Ganz catheter which allowed for blood samples to 
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be taken distal and proximal of the device. The balloon (see Figure 4-1) was 
removed with the aim of supplying oxygen via the Balloon Port, to inflate the 
oxygenator and provide oxygen to the animal during testing. 
 
Figure 4-1: Layout of a Swan Ganz catheter (Author n.d.) 
The oxygenation section of the device was made of a gas permeable Nylon 
membrane, and was heat sealed to ensure the device was mechanically safe. This 
was a possible cause of a weakness in the material which led to the production of 
large bubbles and the damage of the lungs in the in vivo test. Further testing was 
performed on a porcine model and the device was placed within the vena cava by 
insertion via the femoral vein (Figure 4-2 and Figure 4-3) prior to testing being 
performed by two other researchers. For this test, the insertion method was not via 
standard cannulation methods, as the prototype was too large. The device was 
inserted into the porcine model for approximately an hour before oxygenation was 
initiated by using the intravenous device. 
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Figure 4-2: Insertion into femoral vein 
 
Figure 4-3: Swanz-Ganz catheter in position 
Operation of the ventilating machine was continued to allow for ventilation and 
perfusion of the animal during operation. The Swanz-Ganz catheter allowed blood 
samples to be taken directly after the device to investigate the possible increase in 
SvO2 and if there was a change in this value. There would be no need to 
discontinue the use of the ventilating machine, because if oxygenation due to the 
intravenous oxygenator was not sufficient, continuous ventilation would provide 
the animal’s oxygen needs. Oxygen flow was initiated to the device and the 
pulmonary pressure was closely monitored, as this would be the first sign of 
damage to the lungs due to an embolus. The initial pulmonary pressure was 
28/17 mmHg, but after 5 minutes of initiation of oxygen the pulmonary pressure 
was seen to increase to 45/32 mmHg, indicating damage to the lungs of the 
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animal. It could also be seen that the SaO2 (arterial oxygen saturation) decreased 
indicating that there was not only an insufficient amount of oxygen uptake due to 
the intravenous oxygenator, but also that the ventilating machine could no longer 
provide the necessary oxygenation. This indicated possible emboli in the lung 
capillaries. The design and implementation of the device was not successful, 
because the porcine test subject could not be supported by the oxygenation device 
alone, neither could the intravenous oxygenator be implemented as a Respiratory 
Assist Catheter. 
 
At the time of oxygenation however, it was found that the proximal port was 
blocked when attempts at measuring the SvO2 were made. Heparin was 
subsequently added through the distal port in an attempt to physically clear the 
blockage. The blockage could have been due to a blood clot, and the release 
thereof could have been one of the reasons for the damage to the lungs – the 
addition of heparin would have reduced any further clotting. Upon removal of the 
device, it was observed that clotting had occurred and that a layer approximately 1 
mm thick had formed on the outside of the device (Figure 4-4). 
 
 
Figure 4-4: Device after being removed from the porcine test subject – clotted 
layer can be seen alongside the device 
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Upon closer inspection it could be seen that the membrane material had been 
wetted to a degree that there was some plasma leakage through the membrane. A 
hydrophilic material had been used such that smaller bubbles could be formed, but 
it was unsure whether or not the large pores (≈5 µm in diameter) were small 
enough to ensure that small enough bubbles could be produced. 
4.3 Ex Vivo 
Due to the inconclusive result of the in vivo test regarding bubble formation and 
the reason for the damage to the lungs, an external bypass circuit was set up for 
the next test using clear tubing as depicted in Figure 4-5. This circuit could allow 
more accurate inspection of bubble formation and transport, as well as dissolution 
times. This also lessened the complexity of the animal testing because attention 
could be given solely to the interaction of the device within the blood circuit and 
the size of bubbles emanating from the device. Initially, a saline solution was used 
to inspect the formation of bubbles, after which blood was used.  
 
 
Figure 4-5: Ex vivo test circuit 
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In the saline solution, oxygen was fed into the oxygenator to inspect the 
soundness of the seal. During this it was already seen that there were weaknesses 
in the material (Figure 4-7). 
 
 
Figure 4-6: Device is inflated before oxygenation takes place 
 
Figure 4-7: Bubbles seen emanating from weaknesses in the material 
It could clearly be seen that a positive pressure inside the device was required to 
overcome capillary pressure and to initiate the production of bubbles from the 
membrane material. For the ex vivo tests the heat sealing of the membrane was 
replaced by usage of an epoxy to seal the membrane and attach it to the 
embolectomy catheter. A weakness on the surface of the material, possibly caused 
Weakness in 
material 
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during manufacturing of the device or caused during insertion, offered less 
resistance than the pores, and a cloud of large bubbles emanated from the 
weakness. There were also some complications with the bypass circuit where the 
blood was removed from the animal through the jugular vein, as it could be seen 
that the fluid feed rate (determined by the peristaltic pump) was too high and the 
cannula sucked air. Also, one of the T-connectors leaked, causing air to be pulled 
into the blood circuit and making removal of the bubbles a constant concern. A 
filter was placed in the circuit before the fluid was sent back into the animal to 
prevent gaseous emboli.  
 
It was decided that testing would continue, and the device was inserted into the 
saline solution. The blood was then fed into the bypass circuit and the saline was 
pumped back into the storage container. This exposed the oxygenator to the 
deoxygenated blood. Samples were taken distal and proximal of the device with 
the blood flow rate initially at roughly 60 ml/min. The oxygen control valve was 
adjusted to allow pressure to build up inside the device and inflate it, and 
eventually to overcome capillary pressures in the pores and allow bubbles to form. 
At roughly 40 ml/min oxygen, a large amount of bubbles could be seen, which 
collected at the topmost surface of the tubing due to buoyancy forces. These did 
not immediately coalesce, which indicated that if smaller bubbles could be 
produced they will become entrained in the fluid because buoyancy forces are 
dominated by viscous drag (successive pictures can be seen in Figure 4-8 to 
Figure 4-10). Higher blood flow rates could possibly carry smaller bubbles away 
from the formation zone and facilitate blood mixing, and hence oxygen transfer.  
 
Figure 4-8: Initial formation of bubbles 
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Figure 4-9: Collection of bubbles at the surface 
 
Figure 4-10: Formation of oxygen foam 
As the bubbles were seen to form, the oxygen flow was increased to inspect the 
bubble dynamics within the blood. It was found that at higher gas flow rates, a 
larger amount of bubbles were formed, and that bubbles coalesced to form larger 
bubbles, and eventually brittle oxygen foam which was hard to remove. It is 
expected that the coalescence factor in this case was the increased bubble contact 
time. The brittle foam could be caused due to the oxygen drying out the blood at 
the interface, and so creating a harder interface. Oxygen uptake was minimal, due 
to the bubbles being too large and that the exposed surface was too small, but 
could also have been due to the leak in the circuit allowing the blood to become 
almost completely saturated before reaching the oxygenator. This would prevent 
any oxygen to dissolute in the blood.  
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4.4 In Vitro 
Due to the difficulties encountered in the ex vivo test, a circuit was considered 
that did not depend on the animal model. The test circuit was similar in type to the 
one seen in Figure 4-5, but without the animal model. A saline solution was used 
to investigate the increase in partial pressure of the oxygen in the fluid. Again a 
peristaltic pump was used to feed the fluid through the circuit, and knowing the 
length of the tube the dissolving rate of the oxygen in the fluid could be 
calculated. Based on this, knowing the area of the oxygenation section, transfer 
rates per area could be calculated. Samples were taken of the saline fluid before 
and after the device and analysed for the amount of oxygen contained in the 
solution. This would give an indication of the rate of dissolving of oxygen in the 
saline solution. As expected, high pressures were required to overcome capillary 
pressures in materials with small pore sizes. Figure 4-11 shows an example of a 
sample that ruptured before capillary pressure was overcome. 
 
 
Figure 4-11: Tearing of material during in vitro tests 
Analysis of the samples taken before and after the device then showed no increase 
in partial pressure of the oxygen, and in fact that the partial pressure of oxygen 
after the oxygenation section was lower than before the device. This is contrary to 
what was expected, especially since pure oxygen was introduced into the saline 
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mixture. Such deviations are attributed to the samples being taken incorrectly, and 
that the timing between samples were taken was not correlated accurately. This 
would give an apparent reduction in the partial pressure of oxygen as seen in this 
test. Also, slow dissolving rates of oxygen in the saline mixture could cause 
residual concentrations in the sample port from which the samples were taken, 
giving incorrect readings. Due to these tests not being implemented to a degree of 
accuracy well enough to ensure appreciable readings, these results cannot be 
trusted and did not yield any conclusive information. 
4.5 Flow Meter 
4.5.1 Selection Criteria 
Accurate measurements of oxygen flow rate to the oxygenator were necessary in 
order to evaluate the formation of bubbles for specific flow rates and supply 
pressures.  The low flow rates being fed to the oxygenator made the selection of a 
flow meter difficult, as common flow meters used in hospital settings (of the 
rotameter/variable area type) are generally unable to measure such low flow rates. 
Common oxygenators such as ECMOs are often supplied with high flow rates of 
oxygen, and thus do not show a quantifiable indication of flow for flow rates 
below 500 ml/min. Industrial flow meters that measure such low flows are 
available, but are expensive and have a limited accuracy.  
 
For the experiments a flow meter was required and would be manufactured to 
measure the expected flow rates of the oxygen supply to the oxygenator, with 
increments of no more than 10 ml/min and maximum flow rate of 400 ml/min. It 
was decided to use a pressure drop flow meter. According to the Hagen–Poiseuille 
equation, the pressure drop across the length of a tube is directly proportional to 
the flow rate inside that flow tube, and inversely proportional to the fourth power 
of the tube diameter:   
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where Q is the flow rate; 
  L is the pressure drop length of the tube; 
  D is the tube inner diameter; and 
   µ is the gas viscosity. 
 
The Hagen–Poiseuille equation makes the assumption that the flow is laminar, 
viscous and incompressible. Although the assumption of incompressible flow is 
not entirely correct and that the flow is usually expressed relative to the output 
pressure, the small pressure drop and isothermal conditions, as well as the 
assumption of ideal gas behaviour were expected to yield appreciable accuracy at 
low flow rates. The flow tube was selected to ensure that the Reynolds number 
was below 2300 and laminar flow is achieved (a value of Re = 230 was 
calculated), validating the use of the Hagen–Poiseuille equation. The pipe selected 
had to be large enough to ensure that the expected flow rate, and hence velocity of 
the oxygen, resulted in laminar flow, but had to be small enough to ensure that a 
large enough pressure drop could be achieved. The pressure drop is a function of 
the tube diameter, and had to be small enough to yield an adequate resolution. The 
calculations of flow rates and pressure drop, as well as tube diameter can be seen 
in Table E-1 in Appendix E. 
 
4.5.2 Construction and Calibration 
The pressure difference along the length of the tube was measured using a 
Freescale MPXV5004 differential pressure transducer, which outputs an analogue 
signal which is proportional to the differential pressure. The value was sampled 
using the 10–bit A/D converter on board an Arduino Duemilanove 
microcontroller board. This gave a resolution of roughly 5 Pa, which meant that 
the smallest flow that could be measured was 8.7 ml/min. The Atmega 168 
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microprocessor on board the Arduino was programmed for data conversion, 
correct for a DC bias value and to interface with a personal computer for data 
display. The analogue value read from the sensor was multiplied by conversion 
factors to obtain the actual pressure difference, which was then multiplied by a 
factor dependent on the gas being measured (Krelation) to find the flow rate of the 
gas being measured. The value was streamed to the serial (USB) port of a PC, and 
displayed on a simple form which was written in Visual C#.  
 
In order for the measurements to be validated, the flow meter had to be calibrated. 
This was done by measuring the amount of water flowing out of an enclosed tank 
with another opening attached to the flow meter, as shown in Figure 4-12 below. 
 
        
Figure 4-12: Calibration laboratory arrangement 
Air feed 
Flow meter 
Enclosed 
air Tank 
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The volume of water flowing out over a certain period of time would be 
measured, which would correlate to the amount of air drawn into the enclosed 
chamber through the air feed, which as attached to the flow meter. The peak air 
flow rate would be observed (the capacitance of the air would cause this value to 
be reached after a small amount of time), and this correlated to the actual amount 
of water calculated. The average ratio of the actual flow against the calculated 
flow was calculated for the first batch to determine a calibration factor (stored as 
Calibrate), which was then multiplied by the measured flow rate to obtain the 
actual calibrated flow rate. Calibrate was calculated to be 1.153 based on initial 
estimates, which shows a 15 % deviation in the actual flow rate measured for a 
given pressure drop. This is attributed to inaccuracies regarding the diameter of 
the flow tube used which would have a large effect due to the relation of the flow 
rate to the diameter of the tube. Two more batches of calibration tests were 
performed; the result of which are documented in Table E-2 Appendix E. It was 
found that the measured values were within 2 % of the actual values after the 
multiplication factor was included, which falls within an acceptable range. The 
flow meter was implemented in the initial animal tests along with a modified 
rotameter as seen in Figure 4-13 below, where the rotameter was used mainly to 
detect whether or not very small flows existed if the pressure drop flow meter did 
not work. 
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Figure 4-13: Flow meter being used during testing 
4.6 Chapter Summary 
It was found during testing that bubbles small enough to enable dissolution were 
difficult to produce. This is due to an insufficient amount of exposed surface area 
of the bubbles, but also due to the blood not mixing to ensure exposure to the new 
surfaces. In all the tests, there was room for error regarding the measurement of 
data and the determination of oxygen supply such that the concept could not be 
proven adequately. Firstly, in the in vivo tests the outer thrombus which formed 
on the device as seen in Figure 4-4, or large bubbles could have been the result of 
Rotameter 
Flow control 
valve 
Arduino 
microcontroller 
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the increased pulmonary pressure in the porcine model. It could be reasoned that 
the inability to completely oxygenate the animal sufficiently, and the inability to 
provide respiratory assistance results that the implementation of the device was 
unsuccessful.  
 
Secondly, in the ex vivo test, a tear in the material resulted in very large bubbles 
being produced from this site. A leak in the circuit at one of the connector ports 
caused the blood to possibly become saturated with oxygen before reaching the 
device, reducing the oxygen uptake of the blood as supplied by the device to such 
an extent that no dissolution was seen. Large bubbles were formed and the 
consequent foam formed did not allow a sufficient surface area for oxygen 
transfer.  
 
Thirdly, in the in vitro tests, the samples taken before and after the device showed 
that there was no oxygen uptake, but that the partial pressure of the oxygen 
(dissolved oxygen) was lower than before the device. This was unexpected 
considering that pure oxygen was introduced into the system. Bubble coalescence 
was seen due to limited dissolving of the oxygen in the saline solution, which 
minimised the exposed oxygen bubble surface and reduced dissolving of the 
oxygen. 
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5 Modelling Oxygen Diffusion 
5.1 Introduction 
Modelling of physiological process within the human body is often a difficult task 
due to the high complexity of the body as well as unknown factors that affect the 
different processes. Mathematical modelling of these processes does yield several 
advantages though; simulations can be changed with the change of a few parameters, 
whereas changing an experiment with a live model requires re-planning of the 
experiments. Experiments with live models are also time consuming and costly. 
Simulations generally cost less to perform (depending on the complexity of the 
process), and also allow for certain processes to be isolated and inspected 
independently, allowing a higher level of focus and control.  
 
To inspect the performance of an intravenous oxygenator, and subsequently the 
feasibility thereof, the modelling of the diffusion of oxygen from a micro bubble into 
the surrounding blood can yield useful insight. The effect that parameters such as the 
starting radius and the distance between bubbles have on the diffusion rate can be 
inspected, factors that are very difficult to determine in vivo. Literature shows that 
bubbles in close proximity to each other can saturate the blood to such an amount 
that no more diffusion of oxygen takes place out of the bubble and hence the bubbles 
do not decrease in size (Fischer et al. 2009). In essence this indicates that even 
relatively small bubbles with diameter 200 µm introduced into the femoral artery 
could have adverse physiological effects in downstream capillaries and organs 
(Barak & Katz 2005). The modelling of diffusion from a gas bubble into an adjacent 
liquid within the body has similarities to many other processes and industries which 
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require such processes to be modelled (Tan et al. 2000), and hence such models can 
be used as reference for physiological diffusion. 
5.2 Diffusion Model 
5.2.1 Limitations and Focus 
Bubble dissolution in blood occurs due to two factors – first is the dissolving of the 
bubble due to the gas partial pressure (PO2), the second due to the chemical bonding 
of the oxygen to the haemoglobin (SO2). The dissolving process is determined by the 
Hill saturation curve, whereas the bonding process can be described as a chemical 
reaction with kinetic constants for the forward and reverse reactions (Fischer et al. 
2009). The amount of oxygen bound to the haemoglobin is dependent on the PO2 of 
the blood plasma surrounding the red blood cells because the oxygen needs to diffuse 
through the plasma to reach the red blood cells. The case of modelling the dissolution 
of oxygen from a microbubble into surrounding blood is complicated by several 
factors. Firstly, the fact that mass transfer occurs due to diffusion as well as the 
chemical reaction of the dissolved gas and the haemoglobin within the red blood 
cells and the free haemoglobin within the boundary layer (Yang et al. 1971b). This 
reduces the dissolution rate of a bubble within the gas compared to a diffusion-only 
mass transfer, and causes a sharp decrease of bubble size immediately after 
introduction of the gas bubble in the blood. This sharp decrease is only observable 
for a very short time during which a ring of oxygenated blood forms around the 
bubble (Yang et al. 1971a), and is followed by steady shrinkage in the bubble size as 
the oxygen diffuses through the boundary layer and dissolves in the blood  (Yang et 
al. 1971b), (Yang et al. 1971a). Near the moment of complete dissolution the rate of 
shrinkage of the gas bubble is seen to accelerate due to surface tension force (Yang 
1971).   
 
Secondly, the relative motion of the bubble within the blood, such as when the blood 
flows onto and around the bubble or when the bubble rises through a column of 
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blood due to buoyant forces, has an effect in increasing the dissolution rate of the 
bubble due to the thinning of the saturated boundary layer  (Yang et al. 1971b). To 
model the thinning of the boundary layer it is required that convective mass transfer 
properties on the surface of the bubble are known, and calls into consideration the 
use of non-dimensional numbers to determine the ratio of convective mass transfer to 
diffusive mass transfer. For the sake of finding a baseline expression for the bubble 
dissolution rate the bubble will be considered to be in a quiescent blood environment.  
 
Furthermore, mass transfer of oxygen gas from the bubble into the blood causes the 
bubble to decrease in size, and the bubble-blood interface translates with respect to 
the bubble centre. The moving boundary problem is known as the Stefan problem 
and is typically solved by numerical methods only due the non-linear nature of the 
moving boundary problem (Fazio 2000). To address this many numerical methods 
have been employed, which include isotherm migration, finite difference, finite 
element and variational inequalities, which all have purposes for different problems 
(Fazio 2000). One of the most widely used is the fixing-domain approach, where a 
Landau coordinate transformation allows the problem to be reduced to a 
computational domain (Illingworth & Golosnoy 2005), (Fazio 2000). A 
transformation of the moving boundary to Landau coordinates allows for 
computation in the constant Landau coordinate system even though the position to 
which this transformation corresponds actually varies (Illingworth & Golosnoy 
2005). The classical solution to the diffusion problem, however, finds an analytical 
expression for the blood saturation levels at different spatial points within the 
calculation domain at different times. Although this does not allow the Stefan 
problem to be addressed via a Landau transformation, it does allow the solution to be 
derived from first principles and adapted to different modelling purposes. This 
approach will be followed, but to accurately track the bubble interface it will be 
required that spatial and time step sizes are small enough as to not have an effect on 
the movement of the bubble interface. 
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5.2.2 Proposed Solution 
The classical approach to obtain the concentration at different points in the 
calculation domain requires that the solution to the diffusion equation be found. To 
obtain the solution to this partial differential equation it is required that the problem 
be well posed, i.e. consideration is given to the existing assumptions, initial 
conditions and boundary conditions. The feasibility of an intravenous oxygenator as 
implemented in the in vivo experiments could be supported by the solution to the 
diffusion model, if it is found that bubbles released into the bloodstream dissolute 
quickly enough. The dissolution rate of an oxygen bubble within arterial blood in the 
presence of nearby bubbles would increase due to the saturation of the blood around 
the bubble, inhibiting diffusion of oxygen out of the bubble. The conditions at the 
bubble interface can be modelled by a Dirichlet boundary condition and the 
conditions halfway between two adjacent bubbles can be modelled by a Neumann 
boundary condition. The Neumann boundary condition represents the fact that the 
rate of change of the concentration profile hallway between two adjacent bubbles is 
zero and takes on a range of values as time progresses, whereas the Dirichlet 
condition assumes that the blood saturation level (S) at the bubble interface is 100 %.  
 
The mass fraction of dissolved oxygen at the two interfaces mentioned above, and 
the derivation of the solution can be found in Section 5.2.3. The Stefan problem will 
be addressed by mapping of the movement of the interface through a front-tracking 
method (Unverdi 1992), where the position of the interface will be calculated at each 
time interval and this mapped onto an already existing spatial point. The subsequent 
change in length of the calculation domain requires that the concentration profile be 
mapped onto the new discretised domain.  
 
Taking into account the aforementioned limitations as well suggestions made by Dr. 
Kiran Dellimore (Dellimore 2012), certain assumptions can be made which aim to 
contain the focus of the model by simplification without removing the accuracy of 
the results obtained: 
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 The bubble is spherical and surrounded by blood at rest. Spherical symmetry 
exists for the mass fraction distribution of the dissolved oxygen. 
 A clear boundary exists between the phases. No mist or vapour exists around 
the bubble. The only gas within the bubble is oxygen and it is modelled as an 
inviscid ideal gas. 
 The pressure inside the bubble is atmospheric and spatially uniform at all 
times. At the gas-liquid interface diffusion is the only method of gas transfer. 
 Inertial and temperature effects within the bubble and in the blood are 
neglected due to the relatively small size of the simulated bubbles. This 
implies that no temperature gradients exist and hence no convection. 
 Surface tension is neglected. 
 The model is limited to cases where dissolved gases other than oxygen do not 
significantly affect the dynamics of bubble dissolution. 
 The erythrocytes are intact. Free haemoglobin has markedly larger oxygen 
uptake than intact erythrocytes (Coin & Olson 1979). 
 Haemoglobin bound oxygen is assumed to be in equilibrium with the 
dissolved oxygen. 
 Mass diffusion of the dissolved oxygen is governed by Fick’s law with a 
diffusivity coefficient . 
 The concentration of the dissolved oxygen at the gas–blood interface is 
governed by Henry’s law with a constant solubility  , i.e. the amount of 
dissolved oxygen is directly proportional to the partial pressure of oxygen. 
5.2.3 Derivation of Solution 
5.2.3.1 Boundary Conditions and Homogenisation 
 2 ,0 51 PO r mmHg  Prescribes the value of PO2 at all spatial points 
(refer to Figure 5-1) at t = 0.   
Stellenbosch University  http://scholar.sun.ac.za
69 
 2 0, 760 PO t mmHg  Prescribes the value of PO2 at the bubble 
interface, with the assumption that the partial 
pressure of oxygen in the blood at the surface 
of the bubble is as stated in the (Fischer et al. 
2009) 
 2 , 0 
dPO
L t mmHg
dr
  Prescribes the value of the rate of change of 
PO2 at the boundary end. 
 
 
Figure 5-1: Partial Pressure curve vs. distance from the bubble interface 
Now using  
          
2 
STP
d
b
C PO



     (8) 
The following is found: 
         ,0 0.0206dC r               IC1 
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          0, 0.3074dC t              BC1 
            , 0d
dC
L t
dr
              BC2 
Which can be homogenised by setting  
                    , ,dC r t U r t V r                   (9) 
where V = 0.3074, which implies that 
              ,0 0.2868U r                IC2 
   0, 0U t               BC3 
             , 0
dU
L t
dr
              BC4 
5.2.3.2 Partial Differential Equation 
After noticing spherical symmetry, the diffusion equation can be simplified to the 
simplified spherical diffusion equation  
         
2
2
2
 f
Cd Cd Cd
D
t r r r
   
  
   
             (10) 
Which will first be adjusted for the non-homogeneous BC’s by substituting (9) into 
(10). Since all derivations of V = 0, it is  found that 
     
2
t f r rrU D U U
r
 
  
 
             (11) 
5.2.3.3 Separation of Variables 
Equation (11) can now be analysed by setting      ,   U r t R r T t and performing a 
separation of variables, where R(r) is the spatial solution and T(t) the temporal. This 
gives 
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           ( )  fT t TD               (12) 
With the solution 
  ( )  f
tD
T t e

               (13) 
Which can be seen to decay in time. The solution to the spatial component is 
     2 2'' 2 ' 0r R rR Rr                 (14) 
Which decays with an increase in the spatial coordinate. 
5.2.3.4 Bessel Function 
Now, the solution to Equation (14) is a Bessel function. Comparing this to the 
standard Bessel equation (Edwards & Penney 1992) 
             2  0qx y Axy B Cx y                 (15) 
And letting 2K  , it can be seen that 
  2;A   0;B    
2 ; C K   2;q                      (16) 
Which yields the following 
  
1
;
2


  1;    ;k K   
1 
 ;
2
p             (17) 
These can now be used to find a general solution of the form 
          1 2 p pR r x C J kx C J kx                   (18) 
         
1
1 12
1 1 2 1
2 2
 R r r C J Kr C J Kr


 
  
 
            (19) 
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Now, it is known that J(x) is an elementary function if the order of p is half an odd 
integer: 
   1
2
2
sinJ x x
x
          and    1
2
2
cosJ x x
x
           (20) 
Which reduces the solution to 
          
1
2
1 2
2 2
 sin  cosR r r C Kr C Kr
Kr Kr 
  
  
 
           (21) 
And simplifying yields 
                  1 2
1 2
 sin  cosR r C Kr C Kr
r K
                  (22) 
5.2.3.5 Applying Boundary and Initial Conditions 
Using BC3 it can be seen that for the above equation to be physically limited it is 
required that C2 = 0. Therefore,  
                1
1 2
 sinR r C Kr
r K
               (23) 
Thus 
          1 12
1 2 1 2
sin    cos
dR
r C Kr C K Kr
dr r K r K 

             (24) 
And simplifying yields 
               1
1 2 -1
sin  cos
dR
r C Kr K Kr
dr r K r
 
  
 
            (25) 
Applying BC4 the above can be further simplified to 
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           1
1 2 1
sin  cos 0
dR
L C KL K KL
dr L K L
 
   
 
           (26) 
And since         and     can be simplified to  
               cos  sin 0KL KL KL                (27) 
From which the eigenvalue can be found, but because the value of L changes with 
each time step, the eigenvalue will change also. Combining combine R(r) and T(t) to 
get  
     
2
0
1 2
,  C sinn f
K D t
n n
n n
U r t e K r
r K



             (28) 
And using IC2 to determine Cn 
               
0
1 2
,0 0.2868 C sinn n
n n
U r K r
r K


               (29) 
Now, to determine the constant Cn, the inner product in polar co-ordinates is used, 
which is known to be 
 
0
( ), ( ) ( ) ( )
L
f r g r f r g r rdr               (30) 
Which gives 
         
1
0.2868, sin(
 
sin( sin
2
) )(
)
,
n
n
n
n n
K
LK
L
K
C
L
r
K

             (31) 
Which after some simplification yields 
                  
cos(1
0.2868
)2
2
 
n
n n n
n
K
K K K
C
L
L

 
 
                (32) 
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The numerator and denominator must be calculated for each K and L. Now finally, 
combining everything and remembering that Cd = U + V, yields the final solution 
    
0
2
, 0.2868  sinn
Dt
d
n
nr
C r t C e
r L
 



 
   
 
              (34) 
It is however noted that at the bubble interface 
        
0
2 2
lim sinDt Dt
r
nr n
e e
r L L
   

 
 
 
             (35) 
5.2.3.6 Rate of Change of Bubble Diameter 
Performing a mass balance of the gas bubble, it can be seen that the change of mass 
is a function of the flux (Fischer et al. 2009) 
 3 2
4
4
3
STP
d
R R j
dt
  
 
  
 
                       (36) 
Which after some simplification yields the velocity of the interface (Fischer et al. 
2009) 
STP
dR j
dt 
                         (37) 
Now, considering the flux at the bubble-blood interface (Fischer et al. 2009) 
         db
R
C
j D
r



 
  
 
              (38) 
The partial derivative for the rate of change of the concentration can be found 
     
2 1 2 1
 cos  sinn f
K D td
n n n n
n
C
e C K K R K R
r r K R

 
  
  
 
              (39) 
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5.2.3.7 Step-wise Calculation Process 
A step-wise procedure is followed in determining the blood oxygen saturation levels 
at different points for different times. Firstly, the total amount of time is broken 
down by a certain amount of time steps into discreet time intervals at which the 
calculations take place, and the calculation domain (including the bubble radius) is 
broken down into discreet points. Similarly, and taking into account the starting 
radius of the bubble, the domain of blood into which diffusion takes place is 
determined and discrete points at which the oxygen saturation can be calculated are 
created. Secondly, the blood properties, initial values and boundary conditions are 
calculated. Then within the main loop the following procedure is followed for each 
time step, which is implemented in the code (Appendix F): 
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Figure 5-2: Flow diagram for implementation of code 
 Determine the eigenvalue for the calculation domain 
 Calculate the facilitated diffusion - 𝐷𝑓 
 Calculate the Fourier co-efficient - 𝐶𝑛 
 Solve for 𝑇𝑒 and 𝐶𝑑 
 Calculate the saturation gradient for the next time step 
 The rate of change of the bubble interface (𝑑𝑅_𝑑𝑡) and 
the new bubble radius are then calculated 
 
Calculate the length of the new calculation domain and 
create new discreet points based on the shifting of the 
bubble interface. Round off the discrete value and use it 
as an incremental value. 
 Interpolate points from the old calculation domain onto 
the new one 
 Shift the concentration profile according to the position 
of the bubble interface 
 Convert the concentration profile to a saturation 
profile 
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5.3 Discussion 
The aim of determining bubble dissolution times by use of the current model, and 
more specifically determining the accuracy of the model requires that a comparison 
be drawn up with existing models. The parameters as suggested in Fischer et al. 
(2009) are used as a guideline for input values when setting up the current model for 
a run of simulations, with the aim that the results would be compared with those 
mentioned in Fischer et al. (2009) Initially the model has systematically assembled 
from an analytical standpoint, but the difficulties with this approach were 
immediately seen. The input parameters used did not allow the model to run for more 
than one time step due to unrealistically large values for the rate of change of the 
bubble interface, among others. Constraining all these large values for the first few 
time steps in an attempt to stabilise the simulation did not yield the anticipated 
results, although it was identified that certain variables had a larger effect than others 
when constrained to a certain range. The two variables that were immediately 
identified were the Fourier Coefficient, Cn and the diffusion constant D. The value of 
D was constrained by analysing the differences between the results from this model 
with those found in Fischer et al. (2009), and the new values used in all the 
subsequent simulations for different values of  .  
 
To compare the model to Fischer et al. (2009) a simulation was run of the dissolution 
rate of an oxygen bubble in the presence of another oxygen bubble, where the value 
of D adjusted by a factor of 10
-5
 and set equal to 1.8x10
-11
 cm
2
/s. The value of D is 
confirmed comprehensively in Heidelberger et al. as 8x10
-6
 cm
2
/s (Heidelberger & 
Reeves 1990). The distance between the bubble interfaces is larger than the bubble 
radii; the distance between the bubble centres used was   = 500 µm. Drawing 
comparisons to the bubble dissolutions times as suggested in Fischer et al. (2009) 
(Figure 5-3) it can be seen that for the case where   = 500 µm, dissolution times are 
not very similar, but that bubbles do not dissolute fast enough. It is therefore noted 
that bubbles with diameter of more than 200 µm and in close proximity to each other 
(less than 300 µm between surfaces) will not dissolute before reaching the heart or 
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other critical organs, and could cause irreparable tissue damage as mentioned in 
Chapter 2. It has been shown by other researchers that in a 20 % saline solution, 
20 µm bubbles dissolve in 10-16 seconds whereas 10 µm bubbles dissolve in 8-14 
seconds. These conditions were at body temperature and based on linear trends 
(Schubert et al. 2003). Taking into consideration the flow rate of blood in the vena 
cava it can be deduced that bubbles formed in the vena cava would reach the lungs 
within a few seconds, thus substantiating that bubbles smaller than 20 µm might be 
safest. 
 
 
Figure 5-3: Radius-time relations for a bubble surrounded by multiple bubbles 
(Fischer et al. 2009) 
Figure 5-3 also indicates that an increase in distance of the centres of two adjacent 
bubbles would decrease the dissolution time, where the bubble will dissolute fastest 
(roughly 100 seconds) when the distance between the bubbles is appreciably large. 
For smaller distances between bubble centres the larger dissolution time is attributed 
to saturation of the blood with oxygen, which prevents mass transfer of oxygen from 
the bubble into the blood due to a decrease in the concentration gradient. Similar 
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values as seen in the above figure were used as input parameters for the current 
model for two reasons; to determine the bubble dissolution times, as well as 
determine the accuracy of the model.  
 
 
Figure 5-4: Bubble dissolution times (R = 100 µm, D = 1.8x10
-11
 m
2
/s) 
The resultant dissolution times as seen in Figure 5-4 do not correspond to bubble 
dissolution times in accordance with what was expected or when compared to 
literature; a larger dissolution space yields a larger dissolution time. Upon closer 
investigation of the model, and considering the intrinsic differences with numerical 
methods the reason for this difference can be found. The classic method of 
determining the concentration profile as implemented in the current model requires 
knowledge of the length of the calculation domain (i.e. the value of  ) in order to 
determine the eigenvalue (equation (27)). The sinusoidal nature of the equation for 
the concentration profile (equation (28)) is immediately noted, and furthermore that 
the concentration profile is ‘stretched’ to fit onto the calculation domain. In other 
words, every spatial point is ‘aware’ of the value of  , although Fischer et al. (2009) 
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suggest that a saturation boundary layer of 3 R exists irrespective of the value of  . 
The shape of the concentration profile in the current model is a function of the 
eigenvalue, which in turn is a function of the distance between the two bubbles. The 
rate of change of the bubble radius with respect to time is a function of the rate of 
change of the concentration profile with respect to the spatial coordinate at the 
bubble interface (equation (39)). It was also noted that the size of the spatial steps of 
the radial coordinate would also have an effect on the rate of change of the 
concentration profile and was therefore kept constant. Considering the above, it can 
be seen that a larger calculation domain has the effect of a lower rate of change of 
concentration and hence a lower rate of change of bubble radius. 
 
To illustrate the above phenomenon as well as highlight other differences in the 
model to suggested literature, a plot of the blood oxygen saturation vs. radial 
coordinate is shown in Figure 5-5. 
 
 
Figure 5-5: Saturation vs. radial coordinate for Δ = 500 µm (R = 100 µm, D = 
1.8x10
-11
 m
2
/s) 
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It can be seen that the boundary tracking and interpolation method as seen in 
Appendix F accurately tracks the movement of the interface, and should be noted 
that a significant reduction in the spatial step size did not have any effect in the 
bubble dissolution rate. What is also immediately obvious is the sinusoidal nature of 
the concentration profile as mentioned earlier, and that the right boundary (indicating 
half the distance between bubble centres) increases as dictated by the Neumann 
boundary condition.  
5.4 Chapter Summary 
As with most medical devices, the feasibility of an intravenous oxygenator is solely 
determined by two factors. Firstly, the oxygenator needs to achieve its purpose of 
sufficiently oxygenating the blood in order to meet the oxygen needs of a typical 
adult. Secondly, the oxygenator must not cause any serious or substantial harm 
which would negate its use on a patient.  The determining factor would be whether or 
not oxygen bubbles of a size as typically introduced into venous blood by the 
suggested intravenous oxygenator would cause harm to the patient or not. As seen in 
Figure 5-4 and as discussed previously, bubbles which are in close proximity to each 
other and have a diameter equal to 200 µm do not dissolute within 100 seconds, and 
are considered to be potentially harmful to organs which are downstream of the 
oxygenator. Such long dissolution times imply that the bubbles could still be present 
when reaching the heart, lungs, or even the brain, and could potentially get lodged 
within capillaries or accumulate to create bubble clouds. This could cause the 
restriction of blood into tissue and cause necrosis. Based on this data it can be 
concluded that an oxygenator that produces bubbles is not feasible due to the 
overwhelming risk of the bubbles not dissoluting quickly enough.  
 
The mathematical model implemented above to determine the dissolution times has 
been compared to existing models and it has been found that certain limitations exist 
and that incorrect results are possible. It is noted that a numerical method as typically 
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used to solve more complex diffusion problems may be more suitable to address this 
problem and more specifically the Stefan problem.  
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6 Conclusion 
 
The literature review (Chapter 2) indicated that oxygenation can be quantified, and 
that current methods of oxygenation do not address all critical care scenarios. There 
is thus space for an oxygenator that must be available for immediate use and does not 
place extra strain on the lungs of the patient. Considering the requirements of such a 
device (Table 3-1), conceptual designs were developed to investigate whether such a 
device could be developed, and if the blood could be oxygenated via microbubbles. 
Prototypes were developed to test the concept in animal models, although the 
requirements on biocompatibility and insertion methods were not applicable to these 
tests due to an aim in simplicity for the animal tests. It was however seen in the in 
vivo test that profuse clotting on the oxygenation section of the device occurred 
within 90 minutes, rendering the device useless for oxygenation purposes vie 
microbubbles. Damage to the lungs of the animal was sustained, which was assumed 
to be due to gaseous emboli. This was indicated by an increase in pulmonary 
pressure and a decrease in SaO2 while the animal was being ventilated. An ex vivo 
test performed subsequently provided more information regarding the formation of a 
bubble cloud, as well as coalescence of larger bubbles within the blood.  
 
The in vivo test and the ex vivo test did not yield any conclusive information 
regarding the oxygenation of venous blood, nor could approximate dissolution times 
be assessed. The prototypes implemented in the tests were not assessed any further 
according to size requirements due to the lack of sufficient oxygenation, as the 
supply of oxygen was of main concern. Difficulty with the proof of concept to 
investigate the intravenous dissolution of microbubbles in blood can be attributed to 
two factors. Firstly, the testing methods could be improved to a degree that there is 
better control over bubble sizes and bubble separation. The determination of blood 
properties before and after the introduction of microbubbles, as well as the accurate 
control of oxygen flow could yield valuable information regarding oxygen 
dissolution within venous blood conditions. 
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Secondly, the difficulty in proving the concept could be an indication that successful 
implementation of the concept is highly improbable. Considering however that the 
idea was very difficult to prove, even when attempting to perform oxygenation in a 
similar environment to how the device was expected to operate, it was shown that the 
concept may not be feasible. As simulation results show, bubble dissolution times are 
very large even for small bubbles, and that preventing the formation of clouds of 
oxygen bubbles is a very important factor for fast dissolution times, as the 
concentration boundary layer around the bubbles is the main reason for large 
dissolution times (Goerke et al. 2002). The separation of bubbles is however 
impossible with the veins and lobes as seen in Table 3-2, and is a highly idealised 
approach to microbubble dissolution within the blood.  
 
Considering the large risk of introducing microbubbles into the blood, as well as the 
limited dissolution possible, different methods of introducing oxygen into the blood 
intravenously should be considered. According to Yasuda & Lin (2003), a tighter 
control on the free surface energy of the material used to produce bubbles, and hence 
the water contact angle, could lead to smaller bubbles being produced by the 
material. If a material could be produced that has a large water contact angle 
(hydrophilic) and with pores in the 0.1 – 1 µm range, bubbles could possibly be 
produced that are small enough to dissolute before reaching the lung capillaries. A 
suggestion for future work is to manufacture a device with pores of the size 
mentioned previously, that can be produced without compromising the structural 
integrity or biocompatibility of the device. A metal tube, such as stainless steel, 
could be used due to the known properties and large industry that exists for 
producing stainless steel parts and products. This would eliminate the concerns of 
excessively high pressures inside the device, and possibly simplify the manufacturing 
process. Literature shows that surface free energy of such materials can be altered by 
treatment by an atmospheric-pressure plasma jet such that very low contact angles 
can be achieved (Kim 2002). 
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Appendix A Conceptual Designs 
Table A-1: Conceptual RAC designs 
Concept 
Number 
Description Diagram Comments 
1 Star shaped profile, and 
twisted along the length 
of the oxygenation 
section 
 
Increased surface 
area for increased 
oxygen transfer 
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2 Fibres protrude from 
the device in a radial 
manner, and are soft 
enough to take the 
shape of the vein 
 
 
High increase in 
surface area, results 
in an increase in 
complexity and risk 
of fibres entangling 
3 Folding, star shaped 
outer profile, 
determined by the 
preformed membrane. 
Oxygen is supplied 
through the centre. 
 
Can be folded to 
reduce insertion size 
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4 Catheter balloon opens 
slightly in order to open 
the membrane. Balloon 
size determines opening 
of the lobes 
 
 
Smaller size for ease 
of insertion, and 
easily adaptable from 
a catheter. May not 
provide enough 
surface area. 
 
    
                                       (a)                                                (b) 
Figure A-1: (a) & (b) An example of open and closed implementations of cross-
sectional concept 4 
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(a)        (b) 
Figure A-2: (a) & (b) Another example of open and closed implementations of 
cross-sectional concept 4 
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Appendix B Material Screening 
  
                                         (a)                                     (b) 
Figure B-1: Bubble formation from a submerged orifice 
Table B-1: Sample material properties 
Material Description Material 
Hydrophilic/ 
Hydrophobic 
Pore Size 
(µm) 
M1 
PALL LPS high efficiency 
leukocyte removal filter for 
plasma 
Polyester Hydrophilic N/A  
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M2 
Screen Filter for Rapid 
Transfusion of blood 
products 
 N/A  N/A 40 
M3 
Purecell RC high efficiency 
leukocyte removal filter for 
blood transfusion 
N/A   N/A N/A  
M4 
Pall Purecell RN Neonatal 
high efficiency leukocyte 
removal filter for RBC 
 N/A  N/A N/A  
M5 Pall Lipipor TNA Filter  Nylon Hydrophobic 1.2 
M6 Pall Posidyne ELD Filter 
Positively 
charged 
Nylon 
N/A  0.2 
M7 
Pall Lipiguard SB 
Reinfusion filter for 
salvaged blood 
Polyester Hydrophobic 40 
M7b 
Pall Lipiguard SB 
Reinfusion filter for 
salvaged blood 
Cover layer 
(N/A) 
 N/A  N/A 
M8 
Pall Ultipor Breathing 
system filter 
Filter Hydrophobic  N/A 
Nylon  Ultipor, Biodyne A Nylon Hydrophilic 3 
PES Supor 
Polyether-
sulfone 
Hydrophilic 5 
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Appendix C Fluid Properties 
Table C-1: Fluid Properties 
Fluid Density kg/m
3
 (at 
1bar, 20deg C) 
Viscosity Pa.s Surface Tension 
mN/m 
Water 
 
998 1 mPa.s 72.8 
Blood 1060 4 mPa.s 56 
Glycerol 1261 1.2 64 
Aqueous glycerol 
48% (Anon n.d.) 
1120 5.8 mPa.s 68 
Aqueous glycerol/ 
saline mixture 
1125 N/A N/A 
Aqueous glycerol 
50% v/v (Kazakis et 
al. 2008a) 
1140 6.2 69 
Aqueous glycerol 
66.7% v/v (Kazakis et 
al. 2008a) 
1180 16.6 67 
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Air 1.205 1.821x10
-5
 N/A 
Oxygen 1.331 1.92x10
-5
 N/A 
Nitrogen 1.165 1.755x10
-5
 N/A 
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Appendix D Biocompatibility 
 
Figure D-1: ISO decision tree (ISO 2002)  
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Appendix E Flow Meter Calculations 
Table E-1: Flow meter design calculations 
OXYGEN Properties 
 
Colour indication: 
 Density (kg/m3): 1.43 Values to be set: Red 
Viscosity (Pa.s): 2x10-5 Values that can alter: Yellow 
  Intermediate design values: Green 
    
Test Pressure 
Difference (Pa): 250 Tube length (m): 0.92 
Flow rate measured 
(L/min): 0.397 Diameter (mm): 2.11 
Q=P.diff x Kfactor 
 
Area (m^2): 3.5x10-6 
K relation 2.64x10-8 Velocity (m/s): 1.89 
  
Reynolds number: 285.18 
  
Friction factor: 0.22 
  
Entrance Length (cm): 3.61 
  
Introduce entrance length (cm): 4 
    
Table E-2: Flow meter calibration readings and calculations 
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Batch/Sa
mple 
Distance: 
Start - end 
(mm) 
Volume 
H2O 
Time  
Actual 
Flow  
Meas. Flow 
Actual/ 
Measured 
Average 
Tube 
Diameter 
mm 
193.5 
Units:  mm ml sec ml/min  ml/min     Area m^2 0.02941 
1.1 14.5 426.4 75.8 337.5 540 0.625   
  
1.2  7 205.9 61.5 200.83 320 0.628   
  
1.3  10 294.1 138 127.9 215 0.595   
Current value of 
Calibrate = 1.9, multiply 
with Actual/measured to 
receive the actual 
reading 
1.4  9.5 279.4 220.5 76.0 130 0.585   
1.5  23 676.4 128.7 315.3 530 0.595   
1.6  31 911.6 82.6 662.2 1080 0.613   
1.7  9 264.7 121.6 130.6 210 0.622   
1.8  6 176.4 99.6 106.23 170 0.625   
1.9  4 117.6 260.5 27.1 50 0.542   
1.10  7.5 220.6 516.2 25.6 44 0.583 0.604   
 
2.1 13.5 397 84.7 281.2 280 1.004   
  
2.2 11 323.5 103.8 187.0 190 0.984   
  
2.3 27 794 72.4 658.0 645 1.020   
  
2.4  16.5 485.2 148 196.7 195 1.009   
  
2.5  6.2 182.3 161.2 67.9 70 0.969   
  
2.6  17.5 514.6 115 268.5 270 0.994 0.997 
  
3.1 13.5 397 380.7 62.6 62 1.009   
  
3.2 27.5 808.7 106.9 453.9 455 0.998   
  
 3.3 19.2 564.6 74.7 453.5 455 0.997   
  
 3.4 13.1 385.2 265 87.2 90 0.969   
  
 3.5 13.3 391.1 547.2 42.9 45 0.953 0.985 
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Appendix F Mathematical Model 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
Bubble Dissolution Model 
 
Purpose: To obtain the solution to a PDE; more specifically the 
Diffusion Equation in spherical coordinates. Consists of a 
homogeneous equation with Dirichlet LEFT boundary condition and a 
Nuemann RIGHT boundary condition. There is also an Initial 
Condition.  
Author: Wesley Elson    Last modified: 28 January 2014 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
clear 
clc 
format long 
  
%================================================================ 
% Model assumptions:     
%================================================================ 
% Some of the model implemented below is based on the model as 
seen in Fischer et al. (2009), where the following assumptions are 
valid: 
% 1.  The bubble is spherical and surrounded by blood at rest.  
Spherical symmetry for the mass fraction distribution of the 
dissolved oxygen. 
% 2.  A clear boundary exists between the phases. No mist or 
vapour exists around the bubble. The only gas within the bubble is 
oxygen and it is modelled as an inviscid ideal gas. 
% 3.  The pressure inside the bubble is atmospheric at all times 
and spatially uniform at all times. At the gas-liquid interface 
diffusion is the only method of gas transfer. 
% 4.  Inertial and temperature effects within the bubble and in 
the blood are neglected due to the relatively small size of the 
simulated bubbles. This implies that no temperature gradients 
exist and hence no convection. 
% 5.  Surface tension is neglected. 
% 6.  The model is limited to cases where dissolved gases other 
than oxygen do not significantly affect the dynamics of bubble 
dissolution 
% 7.  The erythrocytes are intact. Free haemoglobin has markedly 
larger oxygen uptake than intact erythrocytes. 
% 8.  Haemoglobin bound oxygen is assumed to be in equilibrium 
with the dissolved oxygen. 
  
% ================================================================ 
% A. Prescribing the spatial and temporal properties 
% ================================================================ 
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T = 100; % running time of model [s] 
numtend = 200; % amount of discretised time steps 
dt = T/(numtend-1); % size of time steps 
t = 0:dt:T+dt; % initialising time arrray 
n = 1; % 'mode' of the solution,  
R0(1:numtend) = 0.1E-3; % starting radius of bubble [m] 
dell = input('Distance between bubble centres in mm:'); % distance 
between centres of adjacent bubbles 
del = dell/(1000*2); % converting [mm] to [m], distance from 
centre of bubble to end of comp. space 
L(1) = del - R0(1) % end of spatial boundary [m] 
dx = 5E-7; % spatial step size (total space) [m] 
  
numxend = floor(del/dx) + 1; % amount of discretised spatial steps 
(total space)                 
x = 0:dx:del; % initialising the radial array (total space) 
numrend = floor((L(1)/del)*(numxend)); % amount of discretised 
spatial steps (calc. domain) 
dr = L(1)/(numrend-1); % spatial step size (calc. domain) [m] 
r = 0:dr:L(1); % initialising the radial array (calc. domain) 
  
% ================================================================ 
% B. Prescribing the properties of the blood 
% ================================================================ 
alpha = 0.3; % physical solubility of oxygen [ml O2 / ml blood] 
c = 0.166; % haemoglobin binding capacity [ml O2 / ml blood] 
nn = 2.7; % constant parameter based on physiological condition of 
blood (Fischer et al.) 
rhostp = 1.429; % density of oxygen at STP [kg/m^3] 
rhob = 1060; % density of blood [kg/m^3] 
PO2b = 760; % partial pressure of oxygen at the bubble interface 
[mmHg] 
Cdb = PO2b*alpha*rhostp/rhob; % mass fraction of oxygen at the 
bubble interface 
PO2l = 51; % partial pressure of oxygen at the boundary end [mmHg]   
V = PO2l*alpha*rhostp/rhob; % mass fraction of oxygen at t = 0, 
homogenous solution, based on IC's 
P50 = 28; % parameter of Hill's equation (Fischer et al.) 
C50 = P50*alpha*rhostp/rhob; % parameter of Hill's equation 
(Fischer et al.) 
D = 1.8E-11 % diffusion constant of oxygen in blood [m^2/s] 
lambda(numxend,numtend) = 0; % slope of saturation curve, Fischer 
et al. 
CdOFF(1:numxend,1:numtend) = 0; % initialising the offset matrix 
and setting the value of non-calculated points 
numRoff = numxend - numrend; % amount of discretised offset 
spatial steps 
  
% ================================================================ 
% C. Main loop 
% ================================================================ 
for ti = 1:numtend 
    f = inline('X*cos(X) - sin(X)'); % setting up the eigenvalue 
solution 
    KL = fzero(f,4); % the eigenvalue calculation 
    K = KL/L(ti); % the eigenvalue calculation 
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%     Top = L(ti)*sqrt(pi*K/2); % numerator of the fourier 
coefficient 
%     Bot = (L(ti)/2 - sin(2*K*L(ti))/(4*K)); % denominator of the 
fourier coefficient 
    Top = 0.2868*sqrt(2/(pi*K))*(1/K - cos(K*L(ti))/K); 
    Bot = L(ti)/2; 
    Cn = Top/Bot; % Fourier co-efficient 
    % C.1 Determining the analytical solution 
    for ri = 2:numrend 
        Df = D/(1 + lambda(ri,ti)); % facilitated diffusion 
constant, Fischer et al. 
        Te = exp(-K^2*Df*t(ti)); % solution to temperature 
equation 
       sol = Cn*Te*(1/r(ri))*sqrt(2/(pi*K))*sin(K*r(ri)); % 
general solution 
        U = sol; % forming the summation of the solution 
        Cd(ri,ti) = V + U; % combining homogeneous and non-
homogenoues parts 
        lambda(ri,ti+1) = (c*rhostp*nn/(rhob*C50))*... 
        (((Cd(ri,ti)/C50)^(nn-1))/((1 + (Cd(ri,ti)/C50)^nn)^2)); % 
calculating saturation curve values, to be used in next iteration 
step 
        % C.2 Calculating the new bubble radius 
        dCd_dr = 0.1*Te*(Cn/R0(ti))*sqrt(2/(pi*K))* 
(K*cos(K*R0(ti)) - (sin(K*R0(ti))/R0(ti))); 
        Cd(1,ti) = V + Cn*Te*sqrt(2*K/pi); % the value of Cd taken 
as limit as r -> 0        
        j = -rhob*D*dCd_dr; % mass flux 
        dR_dt(ti) = -j/rhostp; % rate of change of bubble diameter 
    end 
    R0(ti+1) = R0(ti) + dR_dt(ti); % radius of bubble for the next 
time step 
    L(ti+1) = del - R0(ti+1); % diffusion space length for next 
time step 
     
    % C.3 Preparing for interpolation 
    numrnew = floor((L(ti+1)/del)*(numxend)); % new amount of 
discretised spatial steps (calc. domain) 
    drnew = L(ti+1)/(numrnew - 1); % new spatial step size (calc. 
domain) [m]  
    rnew = 0:drnew:L(ti+1); % initialising the new radial array 
(calc. domain) 
    Cdnew(1:numrnew,ti) = interp1(r,Cd(1:numrend,ti),rnew); % 
interpolation procedure 
     
    % C.4 Shifting the concentration profile 
        for ri = 1:numrend 
        CdOFF(ri+numRoff,ti) = Cd(ri,ti); % shifting the 
concentration profile according to the bubble radius 
        CdOFF(1:numRoff,ti) = 0; % setting the value of Cd inside 
the bubble = 0 
        end 
    numRoff = numxend - numrnew; % new amount of discretised 
offset spatial steps 
    numrend = numrnew; % equating the new amount of discretised 
spatial steps to the previous amount 
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    r = rnew; % equating the new radial to the previous radial 
array  
end 
  
clear Cd % clearing unused variables 
clear Cdnew % clearing unused variables 
clear lambda % clearing unused variables 
  
% ================================================================ 
% D. Converting Variables to be used in Plotting 
% ================================================================ 
for ti = 1:numtend 
    for ri = 1:numxend 
        PO2OFF(ri,ti) = CdOFF(ri,ti)*rhob/(alpha*rhostp);                    
% converting the mass fraction of oxygen to partial pressure 
        SOFF(ri,ti) = (PO2OFF(ri,ti)/P50)^nn/(1 + 
(PO2OFF(ri,ti)/P50)^nn);     % converting the partial pressure to 
saturation 
    end 
end 
SOFF = 100*SOFF;                                                             
% converting the saturation to percentage 
%  =============================================================== 
% E. Plotting 
% ================================================================ 
subplot(2,1,1) 
h = 
plot(x(:),SOFF(:,1),'k',x(:),SOFF(:,numtend/5),'r',x(:),SOFF(:,num
tend/2),'c',x(:),SOFF(:,numtend),'b'); 
set (h,'LineWidth',1); 
set (h,'LineWidth',1); 
h=xlabel('x'); 
set(h,'Fontsize',8); 
h=ylabel('S [%]'); 
set(h,'Fontsize',8); 
set(gca,'Fontsize',10); 
title('Oxygen Saturation vs Radial coordinate') 
grid on 
  
grid on 
subplot(2,1,2) 
plot(t,R0,'c',t,L,'r') 
grid on 
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